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Abstract 
 
TSPAN5 is a brain enriched protein member of the tetraspanin superfamily, a group of 
transmembrane proteins some of which have been shown to fundamentally regulate the 
development of mammalian nervous system. This class of proteins presents the peculiar ability 
to clusterize forming specialized membrane region called Tetraspanin Enriched Microdomains 
(TEMs) where they can accumulate other proteins. 
We found that in developing neurons TSPAN5 was mainly present at the surface membrane 
while it was concentrated in an intracellular compartment in the postsynapse of mature 
neurons. We hypothesized that these different localisations could be due to different functions.  
To deepen the first function of the protein, we knocked down the expression of the protein and 
found that this led to a dramatic reduction in the number of dendritic spines. We, thus, 
hypothesized that TSPAN5, through the formation of TEMs, could be responsible of dendritic 
spines formation. We observed in differential lysis of developing rat hippocampal neurons that 
two proteins, fundamental for dendritic spines formation, Neuroligin-1 and GluA2 AMPA 
receptor subunit, were associated with TSPAN5 TEMs. We found that the knockdown of 
TSPAN5 led to increased mobility of Neuroligin-1 and GluA2 AMPA receptors suggesting the 
loss of clusterization typical of the first moments of spines formation. 
To understand the second function of TSPAN5 we identified AP-4 complex as an interactor of 
the C-terminal intracellular tail of TSPAN5. This complex is known to act on AMPARs trafficking 
through direct binding of Stargazin, an AMPARs auxiliary subunit. 
We observed that the knockdown of TSPAN5, carried out after the majority of the 
synaptogenesis was occurred, caused a strong decrease in surface and total level of GluA2. 
Different evidences suggested an involvement of TSPAN5 in vesicular transport of GluA2 and 
we demonstrated that TSPAN5 was necessary for the correct recycling of this receptor.  
These results highlight multiple roles of TSPAN5 in the regulation of both synapse formation 
and synaptic functioning in mammalian brain through two distinct mechanisms of action. 
 
 
 
1 
 
1. Aim of the work 
 
TSPAN5 is a protein conserved in mammals belonging to the tetraspanin superfamily and 
presents the highest level of expression in brain in rodents. 
TSPAN5 transcript has a peculiar expression pattern (Garcia-Frigola et al., 2000; 2001) 
suggestive of roles in central nervous system development more precisely for hippocampus 
and neocortex and thus it was of interest to study this protein function. 
Moreover, as different tetraspanins have been implicated in various functions of neuronal 
development or in direct regulation of neurotransmitter receptors, we were interested in 
understanding whether TSPAN5 could have similar roles. 
In the first part of the project we studied the expression and subcellular localisation of 
TSPAN5 protein identifying a very interesting pattern that highly differs between immature 
and mature neurons. This was suggestive of two possibly distinct functions of TSPAN5 at 
different developmental stages. 
Thus, in the second part of the project, we decided to investigate the role of TSPAN5 and, in 
particular, of the Tetraspanin Enriched Microdomains formed by this protein on plasma 
membrane in immature neurons. We used small hairpin RNA (shRNA) to knockdown the 
protein expression in a model of rat primary hippocampal cultures and identified a profound 
defect in dendritic spines number. We thus subsequently characterized TSPAN5 function in 
this compartment by means of biochemical and super-resolution live imaging technique. Our 
results suggest that the protein could directly act in dendritic spines formation, a process that 
is far from being fully understood, despite the great amount of work done during past years to 
elucidate its various steps. 
The third part of the project was aimed to unravel the function of TSPAN5 in mature 
synapses where the protein seemed redistributed to intracellular compartments. We used a 
Yeast Two-Hybrid Screening to identify intracellular partners of the protein and isolated AP-4, 
an adaptor complex involved in AMPA receptors trafficking. We thus investigated this 
process with various biochemical and imaging techniques and demonstrated a direct role of 
TSPAN5 in regulating GluA2 AMPA-Rs subunit recycling. This complex series of events 
regulated by a plethora of proteins is necessary to maintain the correct balance of receptor 
on neuronal plasma membrane and as a result the proper functioning of brain circuits. 
Our results identify TSPAN5 as a regulator of both synapses formation and function with two 
distinct activities that are separated by their developmental stage of action. This makes 
TSPAN5 a new fundamental player in excitatory synapses and increases our level of 
knowledge in brain functioning. 
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2. Introduction 
 
2.1 Tetraspanins 
2.1.1 Tetraspanin superfamily 
The tetraspanins are a superfamily of evolutionarily conserved transmembrane proteins with 
a molecular weight varying from 25 to 50 KDa. They are abundantly expressed almost in 
every cell type and tissue. The whole superfamily shares the basic structure that is 
composed of four transmembrane domains, two extracellular loops (EC1 or Small 
Extracellular Loop (SEL) and EC2 or Large Extracellular Loop (LEL)) and short intracellular 
N-terminal and C-terminal tails (Figure 1) (Wright & Tomlinson, 1994) (Maecker et al., 1997) 
(Kovalenko et al., 2005). 
 
 
Figure 1. Tetraspanin structure. Tetraspanins are characterized by four transmembrane domains (with conserved 
charged residues; blue circles), a small (EC1 or SEL) and a large extracellular domain (EC2 or LEL), a very small 
intracellular loop, and short cytoplasmic N- and C-terminal tails. Sites of conserved palmitoylation at 
juxtamembrane residues are depicted in red. One CCG motif and 2–8 additional cysteine residues are found in 
the LEL domain, forming intramolecular disulfide bridges (dotted lines). (Bassani & Cingolani, 2012) 
 
The extracellular domain LEL is generally divided in two regions: one is conserved and 
contains α-helices A, B and E and is likely involved in dimerization and/or binding to other 
tetraspanins; the second is comprised between helices B and E and differs among different 
tetraspanins conferring interaction specificity (Berditchevski et al., 2001) (Stipp et al., 2003). 
Other conserved regions found in tetraspanins are a CCG motif right after the B helix, a 
PXXC motif and a cysteine proximal to the fourth transmembrane domain. These cysteines 
form disulphide bridges that allow the correct folding of the LEL. However, some tetraspanins 
possess additional cysteines in the LEL with a maximum number of eight. 
SEL domain function is unknown but it is thought to mainly promote and stabilize LEL folding. 
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The transmembrane domains are the most conserved among the superfamily and contain 
polar residues that could form hydrogen bonds thus stabilizing the structure of the whole 
protein (Bienstock & Barrett, 2001). Residues on the intracellular side but positioned closed 
to the membrane could undergo palmitoylation modification as shown in Fig 1. 
The short intracellular C-terminal tail presents the highest degree of divergence between 
family members. These tails are known to participate in some signalling cascades 
modulating many biological processes such as proliferation, migration, differentiation and 
cell-cell adhesion through interaction with other proteins. In particular, a strong association 
has been found between the tetraspanins CD63-CD81 and the phosphatidylinositol-4 kinase 
likely acting on cell motility (Yauch et al., 1998) (Berditchevski et al., 1997) (Zhang et al., 
2001) (Stipp et al., 2003).  
Thirty-three different tetraspanins are known in Homo sapiens; they do not have receptor 
function even if they are exploited by some microbes to enter the cells: hepatitis C virus 
protein E2 binds CD81 (Pileri et al., 1998) and FimH of uropathogenic bacteria binds the 
tetraspanin Uroplakin 1A (Wu et al., 1996). This family is involved in the pathogenesis of 
many diseases. Mutations, usually occurring on the EC2 domain, in peripherin/RDS lead to 
several retinal disorders probably disrupting photoreceptor morphogenesis (Kohl et al., 1998) 
(Figure 2).  
 
Figure 2. Genetic analysis of tetraspanins function up to date (Hemler, 2005). 
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Many members of this family have important functions in the immune system: the CD81-
CD19 complex is fundamental for B and T cells (Maecker & Levy, 1997) (Miyazaki et al., 
1997) (Deng et al., 2000). However, mutations directly related to pathologies are generally 
rare in genes of the tetraspanin superfamily likely due to possible functional redundancy. 
Recently tetraspanins have also been suggested as promising drug targets in numerous 
illnesses considering that they could be easily reached on their extracellular domains 
possibly interfering and modulating the activity of their intracellular partners (Hemler, 2008). 
 
2.1.2 Tetraspanin Enriched Microdomains (TEMs) 
All tetraspanins are able to form specialized membrane domains named Tetraspanin 
Enriched Microdomains (TEM) where they interact each other and with other proteins (Figure 
3). 
 
 
Figure 3. Representation of the Tetraspanin Enriched Microdomain (TEM), Tetraspanins are shown in shades of 
green; partners of the immunoglobulin superfamily are shown in magenta and brown, and those of the integrin are 
in blue. (Levy & Shoham, 2005). 
 
In particular TEMs have been found to accommodate many different proteins such as 
Integrins, members of the Ig family (e.g. MHC I and II), proteoglycans, growth factor 
receptors etc. (Boucheix & Rubinstein, 2001). 
Accordingly, the main hypothesis for tetraspanins function is that they could act as molecular 
facilitator connecting the different actors of many processes in the TEMs; these interactions 
are unlikely to happen randomly and the ability to concentrate proteins in small membrane 
domains would result in increased likelihood (Maecker et al., 1997). The domain responsible 
of these interactions is the EC2 loop (Boucheix & Rubinstein, 2001). 
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These domains are highly enriched in cholesterol and the palmitoylations that occur as post-
translational modifications are involved in the direct binding of tetraspanins to this lipid 
(Charrin et al., 2003) (Silvie et al., 2006). This interaction contributes to the physical 
separation of TEMs from the rest of the membrane due to different lipidic composition. This 
composition also causes the TEMs to be very insoluble in numerous lysis buffer leading to a 
variety of problems in studying this family of proteins and in particular in the definition of 
specific interactors.  
Indeed, the lysis in mild detergent buffer (containing CHAPS or Brij as detergents) is able to 
solubilize only partially the domains and co-immunoprecipitation experiments performed in 
this condition would reveal not only specific interactors but also proteins that are present in 
the TEMs due to interaction with other tetraspanins. The high cholesterol concentration, 
however, gives us also a tool to circumvent this problem. 
The lysis in buffer containing digitonin, a detergent that exerts its action by binding to 
cholesterol, and the subsequent centrifugation of the samples gives the possibility to 
completely remove TEMs from the preparation allowing to detect specific interactors of the 
selected tetraspanin that would have been extracted as monomer from the TEMs. 
Tetraspanin interactions are generally divided in three levels:  
1) When the interaction is resistant to strong detergent (e.g. Triton X-100) suggesting direct 
binding that occurs at high stoichiometry. These interactions are the only ones believed to 
occur directly;  
2) When the interaction is less robust and not resistant to very strong detergent but occurring 
in hydrophobic reagents (such as Brij 96). These interactions usually involve other 
tetraspanins; 
3) When the interaction is detectable only in very mild detergent (e.g. CHAPS) that would 
completely fail in solubilizing TEMs. 
Level 2 and 3 interactions are thought to occur mainly through TEMs. 
A very recent study based on super-resolution imaging techniques studied the organization 
of TEMs formed by tetraspanins (Zuidscherwoude et al., 2015). 
This study proposed that different tetraspanins organize separate TEMs with distinct mobility 
characteristics and localisations instead of having domains where many different tetraspanin 
members can cohabitate. These domains appear to have a medium size of 120 nm 
containing less than 10 molecules per domain. This result is comparable with previous 
ultrastructural observation of TEMs that have suggested an area of 0,2 μm2 (Nydegger et al., 
2006). The authors also proposed that these domains on the surface membrane form a 
dynamic network that is regulated by the weak heterotypic interaction between the different 
tetraspanins of different TEMs or with other proteins. 
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Different studies suggest that it is possible to act on TEMs formation, either inducing or 
preventing, by applying monoclonal antibodies directed against extracellular epitopes with 
consequent downstream effects (Hemler, 2008). 
 
2.1.3 Tetraspanins in the brain 
Several tetraspanins have been found in the nervous system, including CD9, CD81, 
TM4SF2/A15, TSPAN2, TSPAN3/OAP-1, TSPAN5 and neurospanin, where some of them 
act on neurite extension (Schmidt et al., 1996) (Banerjee et al., 1997) and synapse 
maturation (Kopczynski et al., 1996) and two members have been involved in forms of 
mental retardation: TSPAN6 (Vincent et al., 2012) and TSPAN7 (Zemni et al., 2000). 
CD81 has been involved in astrocyte and microglia functioning as knockout mice for this 
gene showed enlarged brain with increased number of astrocytes and microglia (Geisert et 
al., 2002). 
Tetraspanin-7 (TSPAN7) has been found mutated in forms of X-linked Intellectual disabilities 
(XLID) (Zemni et al., 2000) (Bassani et al., 2012). The protein, almost ubiquitously expressed 
but most strongly in brain (Hosokawa et al., 1999), was found mutated in different ways (a 
X;2 balanced translocation, a premature stop codon and a missense substitution) in patients 
affected by intellectual disability (Zemni et al., 2000). Bassani and colleagues has 
characterized TSPAN7 as active in dendritic spine stabilization and filopodia formation during 
rat hippocampal neurons development leading to a functional maturation of the synapses 
(Bassani et al., 2012). Silencing TSPAN7 leads to a phenotype characterized by normal 
spine density but with a reduced spine width and reduced expression of synaptic markers. It 
also causes a faster spine turnover dynamics. TSPAN7 appears to interact, through its C-
terminal domain, with Protein Interacting with C-Kinase 1 (PICK1), integrin and GluA2/3, a 
subunit of AMPA receptor (α-Amino-3-hydroxy-5-Methyl-4-isoxazolePropionic Acid, AMPA-
Rs).  This complex seems to be important to stabilize AMPA receptors on dendritic spines 
considering that the silencing of TSPAN7 leads to faster internalization of the receptor while 
the silencing of PICK1 decreased it. Both TSPAN7 and GluA2/3 bind PICK1 at its PDZ 
(Postsynaptic density protein (PSD-95), Drosophila disc large tumor suppressor (Dlg1), and 
Zonula occludens-1 protein (zo-1)) domain likely competing for this site; this could explain 
the opposite effects of TSPAN7 and PICK1 on GluA2/3 internalization. 
 
2.1.4 Tetraspanin 5 (TSPAN5) 
Human TSPAN5 gene (alternative name: NET-4; tetraspan 5; TM4SF9; transmembrane 4 
superfamily member 9; transmembrane 4 superfamily, member 8) is located on chromosome 
4q23 and has a 3365 bp long sequence divided in 8 exons; it encodes for a 268 
amminoacids long protein (Entrez Gene).  
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It was first identified by Todd and colleagues in 1998 (Todd et al., 1998) where they showed 
a prevalent presence of the mRNA transcript in human brain. 
It is conserved in chimpanzee, rhesus monkey, dog, cow, mouse, rat, chicken, zebrafish, fruit 
fly, and C.elegans (tsp-12) and it is a typical member of the tetraspanin superfamily with 
which it shares the structural characteristics as it is inferred by sequence homology. It is part 
of the C8 subgroup of tetraspanins, clustered by the presence of eight cysteine residues in 
the LEL. 
The mouse protein sequence contains four N-glycosilation and six myristoylation sites and a 
putative Protein Kinase C (PKC) phosphorylation site at the intracellular N terminal tail 
(Garcia-Frigola et al., 2000). 
Very little is known about this protein. It has been found involved, together with another 
tetraspanin, NET6, in osteoclastogenesis where it seems to promote the cell fusion that is 
necessary to produce osteoclasts. In fact the TSPAN5 mRNA appears to be up-regulated 
upon activation of RANKL (Receptor activator of nuclear factor kappa-B ligand), the system 
that specifically induces the osteoclastogenesis in mononuclear macrophage/monocyte 
lineage precursor (Iwai et al., 2007). 
TSPAN5 mRNA presence in mice has been extensively studied and it is detected at high 
level in the brain, at lower level in heart, kidney, testis and weakly in lung and liver. In mouse 
brain the transcript is first detected at embryonic day 13-14 and it reach his peak at P0 
strongly decreasing at P10 (Figure 4). 
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Figure 4. A) Northern blot analysis of mouse TSPAN5 mRNA within different mouse tissues. B) Whole brain 
northern blot at different developmental stages. Table) Level of expression of mouse TSPAN5 mRNA in different 
brain areas and at different developmental stages. (+/−) very low, (+) low, (++) moderate, (+++) high, (++++) very 
high (Garcia-Frigola et al., 2000) (Garcia-Frigola et al., 2001). 
 
At prenatal and postnatal stages, the transcript is highly regulated with its expression pattern 
strongly varying in time and in different brain areas. It remains expressed from E14 to 
adulthood at very high level in the whole hippocampus and in the neocortex. In the 
adulthood, high signal is present also in the cortical structures such as the layer II-III and IV-
V of the cortex, the piriform cortex and the entorrhinal cortex interneurons, and in the 
amygdala, in the medial sectum and in the olfactory bulb. In the cerebellum the transcript is 
preferentially expressed in the Purkinje cells. (Garcia-Frigola et al., 2000, Garcia-Frigola et 
al., 2001). The expression pattern strongly suggests that mouse TSPAN5 could have a 
relevant function in the Central Nervous System and specifically in the development and 
functional maturation of hippocampus and neocortex. 
A recent paper has shown that Tsp-12, the TSPAN5 ortholog in C. elegans, is a key 
regulator of Notch activity likely promoting its cleavage by γ-secretase (Dunn et al, 2010). 
Similar results have been published later confirming these findings also in mammals and 
pointing out TSPAN5-dependent activation of ADAM10 (A Disintegrin And Metalloprotease 
domain 10), another metalloprotease involved in Notch activation (Haining et al., 2012) 
(Dornier et al., 2012). 
Notch is an extensively studied protein that mediates cell-cell interactions involved in the 
specification of the cell fate in animal development. It is fundamental in the regulation of 
migration, morphology, synaptic plasticity and survival of immature and mature neurons as 
well as in the development of the brain. Notch signalling is involved in Allagile, CADASIL 
(Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and 
Leukoencephalopathy), Hajdu–Cheney syndromes, Down’s syndrome and Alzheimer’s 
disease (Ables et al., 2011). Notch is present at the cell membrane as heterodimer between 
its amino and carboxy terminal. The binding of its ligand, Delta/Serrate/LAG-2 family, causes 
the cleavage at the juxtamembrane portion by ADAM disintegrin and metalloprotease. This 
event creates the substrate for γ-secretase that cutting the protein in its transmembrane 
domain releases the intracellular active domain. The domain reaches the nucleus where it 
interacts with CBF1/Suppressor of Hairless/ LAG-1, Mastermind/SEL-8 and other DNA 
binding proteins to activate transcription of specific genes. 
In a silencing screening of 21 tetraspanins in a C. elegans germ line with Notch constitutive 
active, tsp-12 came out as the sole able to suppress the sterility of the line induced by Notch 
overactivity. A null allele of tsp-12 synergized in causing embryonic lethality with glp-1 (one 
of the Notch ortholog protein in C. elegans) and in enhancing the phenotype caused by the 
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loss of function of ADAM10 and ADAM17/TACE, both involved in Notch processing. Tsp-12 
has many human orthologs: TSPAN17, TSPAN14, TSPAN15, TSPAN10, TSPAN33 and 
TSPAN5. Human Notch1 is constitutively active in forms of T cell acute lymphoblastic 
leukemia (T-ALL). Using HeLa cells carrying the mutations responsible for this constitutive 
activity and silencing the different Tsp-12 human orthologs the authors identified TSPAN33 
and TSPAN5 ability to reduce Notch1 transcript abundance. The use of truncated forms of 
Notch resembling the cleaved protein by ADAM or by γ- secretase showed that the silencing 
of TSPAN33 reduced the active form of Notch only in the ADAM cleaved form demonstrating 
that this tetraspanin is involved in γ-secretase cleavage. The silencing of TSPAN5 synergized 
with the silencing of TSPAN33 in reducing the membrane bound, constitutively active form of 
Notch. The authors thus proposed that the modulation of TSPAN5 was able to modify Notch 
cleavage and then its activity. This role of TSPAN5, however, seems not to be highly specific 
as other members of the tetraspanin family can exert the same or at least very similar 
function on metalloproteases; for instance all the C8 subgroup, (Haining et al., 2012) (Dornier 
et al., 2012), Tetraspanin 12 (Xu et al., 2009) and Tetraspanin 15 (Prox et al., 2012) have 
been shown to have such activity. 
 
2.2 Dendritic spines formation 
This paragraph will shortly describe the sequential phenomenons required for the correct 
formation of dendritic spines, the postsynaptic compartment of excitatory synapses highly 
present in hippocampus, as we identified TSPAN5 as a key player in this cascade of events. 
Synapse formation is a very complex process that requires many different steps to occur in a 
precise spatial and temporal scale. Of course, the correct chain of all these events is crucial 
for establishing connections between neurons and thus for the formation of brain circuits and 
for its proper functioning. Glutamatergic synapses are the most abundant excitatory 
synapses existing in the brain; they have the peculiarity of being built, on the postsynaptic 
side, on specialized membranous protrusions called dendritic spines (Nimchinsky et al., 
2002, Sheng & Kim, 2002). The importance of number and shape of dendritic spines is 
underlined by the fact that alterations in these parameters have been found in many 
neurological and psychiatric diseases and in particular in many forms of intellectual disability 
and autism spectrum disorders (Figure 5) (Fiala et al., 2002). 
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Figure 5. Dendritic spines number (both reduction and increase), shape (both in length and width) and positions 
defects are associated with many different forms of intellectual disability, epilepsy and other neurological 
conditions (Fiala et al., 2002). 
 
These organelles are extremely dynamic, as they can be formed very rapidly and very rapidly 
removed (in the order of minutes) (Bonhoeffer & Yuste, 2002) but they can also remain 
stable for days or months. They are thus thought to be the major repositories of long-term 
memory in the brain and are in fact found at very high density in hippocampal pyramidal 
neurons (Segal, 2005). Despite the extensive studies that have addressed the process of 
spines formation in the past years, the picture is far from being complete. 
Different hypotheses exist for the very first steps of spines formation and in particular on the 
definition of the place where a spine is going to be formed (for a review see (Yuste & 
Bonhoeffer, 2004). The hypotheses differ mainly on the relevance of axonal contact for the 
formation of the spines and on the importance of filopodia in this process. However, we are 
not going deeper in this topic as it is out of the specific importance of our work. 
Nevertheless, it is necessary that an intracellular cascade takes place to have the formation 
of the complex postsynaptic network of proteins composed of receptors, adhesion molecules 
and scaffold proteins. Adhesion molecules are thought to be crucial in the initial signalling as 
they can bind physically the dendritic spine to the forming presynaptic bouton. Neuroligins 
are for sure among major players in this process. This family of type 1 transmembrane 
proteins, that in humans counts five members, Nlg-1, Nlg-2, Nlg-3, Nlg-4 and Nlg-4Y (Jamain 
et al., 2003), has been associated with postsynaptic formation in numerous studies. This role 
is related to their ability to bind presynaptic Neurexins (Sudhof, 2008) thus forming a stable 
bridge across the synaptic cleft and to the interaction with intracellular scaffolding proteins 
(Figure 6).  
 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Neuroligins extracellular and intracellular interactors in excitatory and inhibitory synapses (A). 
Neuroligin 1 is the major trans-synaptic adhesion molecule that organizes scaffold proteins (PSD-95, S-SCAM 
etc.) and thus all receptors in excitatory synapses. Neuroligin 3 and other adhesion molecules (SynCam, EphrinB, 
etc…) participate in the formation of this complex (B). Neuroligin 2 is instead the major organizer of inhibitory 
postsynapse. (Chia et al., 2013). 
 
Neuroligins present a specificity for excitatory or inhibitory synapses with Neuroligin 1 being 
the main trans-synaptic adhesion molecule for excitatory (Song et al., 1999) and Neuroligin 2 
for inhibitory (Graf et al., 2004) (Varoqueaux et al., 2004) but they can exchange position to 
some extent. 
The importance of Neuroligins for brain functioning is pointed out by the finding that 
mutations in Neuroligin 3 and 4 genes are associated with autism spectrum disorders and 
intellectual disability (Jamain et al., 2003) (Chih et al., 2004) (Comoletti et al., 2004) 
(Laumonnier et al., 2004) (Talebizadeh et al., 2006). 
On the intracellular side Neuroligin 1 is able to bind PSD-95 (Postsynaptic Density-95), the 
main excitatory scaffold protein, on one of its PDZ domains but also many other scaffolding 
such as other MAGUKs (Membrane-Associated GUanylate Kinases), S-SCAM (Synaptic 
SCaffolding Molecule), SHANK (SH3 And multiple ANKyrin repeat domains protein) and 
PICK1 (Irie et al., 1997) (Iida et al., 2004) (Meyer et al., 2004). This ability to recruit 
scaffolding essential for postsynapse assembly suggests that Neuroligin 1 can be the first 
protein that localises in the forming dendritic spines. It creates homo-multimers through its 
catalytically inactive acetylcholinesterase (AChE)-homologous domain (Comoletti et al., 
12 
 
2003) (Dean et al., 2003) thus increasing the strength and the stability of the synapse via 
binding to neurexins. 
The relevance of Neuroligins in spines formation is demonstrated by the fact that the 
overexpression of Neuroligin 1 leads to increase number of dendritic spines in cultured 
neurons (Levinson et al., 2005) and conversely its knockdown decreases spines density 
(Chih et al., 2005). Moreover, the ectopic expression of Neuroligins in HEK (Human 
Embrionic Kidney) cells is sufficient to induce the formation of mature presynaptic terminals 
in contacting neuronal axons (Scheiffele et al., 2000) (Fu et al., 2003) (Sara et al., 2005) and 
on the other side the expression of neurexins in HEK cells gives rise to postsynapses in 
associated dendrites (Graf et al., 2004). These effects are so strong that they can be 
mimicked using microspheres coated with Neuroligins or Neurexins respectively (Dean et al., 
2003) (Graf et al., 2004). 
Neuroligin 1 is present on the surface of neurons and it is organized in clusters even before 
the contact event between dendrite and axons. However, the recruitment of Neuroligin 1 to 
sites of contact occurs very rapidly, in the order of 1-3 minutes, mainly from the freely 
diffusing pool (Barrow et al., 2009). An extensive study of the dynamics of the events 
occurring after axon-dendrite contact made by Barrow and colleagues (Barrow et al., 2009) 
observed that the clusterization of Neuroligin 1 at this site is sufficient to induce the 
recruitment of PSD-95 in 30-60 minutes in a palmitoylation dependent manner. PSD-95 
appears to be mobilized from existing synapses to be redirected to the newly formed ones 
(Mondin et al., 2011). The arrival of NMDA receptors (N-methyl-D-Aspartate receptor) 
appears to be almost concomitant to the clusterization of Neuroligin 1 but the transport 
seems to be happening in intracellular vesicles somehow linked to surface Neuroligin 1. 
AMPA receptors are instead recruited with slower dynamics showing a peak accumulation 
after 1-2 hours from the axon-dendrite contact (Friedman et al., 2000). Moreover, different 
works have analysed at super-resolution level the diffusion of AMPA-Rs in physiological 
condition and upon different stimulation (Heine et al., 2008) (Mondin et al., 2011) (Nair et al., 
2013) (Constals et al., 2015). 
It seems that AMPA-Rs are recruited to Neurexin-Neuroligin contact sites thanks to PSD-95, 
which can bind Stargazin, the main TARP (Transmembrane AMPA receptor Regulatory 
Protein) at its PDZ binding site.  
Consistently with these observations, the knockdown of either Neuroligin 1 or PSD-95 
decreases AMPA-Rs clusters and increases its diffusion; reverse effects are observed upon 
overexpression of the two proteins suggesting that Neuroligin 1, through PSD-95, act as a 
trap to immobilize freely diffusing AMPA-Rs (Mondin et al., 2011) (Figure 7). 
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Figure 7. Possible model of formation of the postsynaptic proteins complex with the depiction of Neuroligin-
neurexin contacts (1.Adhesion formation) and the sequential recruitment of PSD-95 (2. PSD scaffold recruitment) 
and AMPA-Rs through Stargazin binding and trapping (3. AMPAR trapping) (Mondin et al., 2011). 
 
Moreover, it appears that AMPA-Rs dimers are differentially regulated at Neurexin-Neuroligin 
contact sites. In particular, GluA2 is accumulated at these locations whereas GluA1 is not. 
This discrepancy is likely due to differential requirement of neurotransmitter release from the 
presynaptic side. In fact, GluA2 recruitment is independent from NMDA activation, as it 
occurs also in presence of Tetradotoxin (TTX) and APV (DL-2-Amino-5-phosphonoPentanoic 
acid), very well-known blockers of action potentials and NMDA receptors respectively (Heine 
et al., 2008). In contrast, GluA1 accumulation appears to require glutamate release, as it 
does not occur in conditions where the presynaptic side is not directly present but only 
mimicked by using latex beads coated with Neurexins. In addition, when a real axon-dendrite 
contact site is examined the recruitment of GluA1 is blocked by application of TTX/APV.  
 
2.3 Adaptor Protein Complex 4 (AP-4) 
This section will provide a brief explanation of the structure and function of AP-4 as, with our 
study, we identified this protein as a new TSPAN5 direct interactor. 
AP-4 is a heterotetrameric complex conserved in mammals, chicken, Dycostelium 
discoideum and Arabidopsis taliana (Boehm & Bonifacino, 2001) that was discovered 15 
years ago (Dell'Angelica et al., 1999) (Hirst et al., 1999). It belongs to the family of Adaptor 
Proteins (APs). This family of protein complexes counts five members (AP-1-5) all composed 
of four subunits: two large subunit (β1-5 and γ, α, δ, ε and ζ), one medium (μ1-5) and one 
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small subunit (σ1-5) (Figure 8) (Hirst et al., 2013). These subunits are strictly associated and 
they cannot be observed in monomeric form probably due to high rate of degradation.  
 
Figure 8. AP-4 complex structure. The four subunits are represented with different colours: ε in magenta with the 
hinge linker and the ear (or appendage) domain, β4 in blue with the hinge and the ear domain, µ4 in orange and 
σ4 in green. As depicted, µ4 and σ4 together with the main part of ε and β4 represent the core of the complex that 
is in close proximity with membranes. (modified from (Mattera et al., 2015). 
 
AP-1, AP-2 and AP-3 have been extensively studied in past years and different roles have 
been established. On the opposite, AP-4 and AP5 have been more recently described and 
little is known about their function. 
In general AP complexes are able to form protein coat (mainly clathrin-coat) on different 
membranous organelles and, through the recognition of signal motifs on cargoes protein, to 
associate them to vesicles that are then transported to specific compartments, mainly 
through motor proteins (Owen et al., 2004).  
For example, AP-1 is involved in vesicular transport between Trans Golgi Network (TGN) 
and endosomes and in sorting membrane proteins to the basolateral compartment, AP-2 
mediates internalization from the plasma membrane of many different proteins and AP-3 can 
direct proteins from endosomes to lysosome-related organelles such as melanosomes 
(Bonifacino & Traub, 2003) (Dell'Angelica, 2009). 
At least AP-1 and AP-4 has been involved in sorting proteins in polarized cells, such as 
epithelial cells and neurons, to the basolateral compartment (named somato-dendritic in 
neurons) (Farias et al., 2012) (Guo et al., 2013) (Matsuda et al., 2008). 
The signal motifs recognized by AP complexes are quite various with the two main being 
dileucine based ([DE] XXXL [LIM]) and tyrosine based (YXXØ with Ø being a bulky 
hydrophobic amminoacid). The first is generally bound by γ and σ1 for AP-1, α and σ2 for 
AP-2 and δ and σ3 for AP-3 (Janvier et al., 2003) (Chaudhuri et al., 2007) (Doray et al., 
15 
 
2007); the second instead is recognized by C-terminal domain of μ (1-3) (Ohno et al., 1995) 
(Ohno et al., 1996).  
α of the AP-2 complex interacts with many regulators of coat machinery or vesicles assembly 
(Owen et al., 2000) and β 1, 2 and 3 interact directly with clathrin (Gallusser & Kirchhausen, 
1993) (Shih et al., 1995) (Dell'Angelica et al., 1998). σ1 and 3 are required for functional 
integrity of the complex (Shim et al., 2000) (Mullins et al., 2000). 
Compared to the other AP complexes AP-4 presents some peculiarities: first of all no 
association with clathrin has been observed and signal motif differs. Indeed, it is capable of 
binding only YXXØ motif for example of CD63, LAMP-1, LAMP-2 (Lysosomes-Associated  
Membrane Proteins 1 and 2) and TGN38 (Trans Golgi Network integral protein 38) (Hirst et 
al., 1999) (Stephens & Banting, 1998) (Aguilar et al., 2001). However, these interactions are 
weak and do not seem to be fundamental for proteins localisation, as the removal of AP-4 
does not alter it (Simmen et al., 2002) (Janvier & Bonifacino, 2005). μ4, instead, 
preferentially binds signals motif such as F YD[PR]F (Aguilar et al., 2001) or YX [FYL] [FL] E 
(Burgos et al., 2010). 
AP-4 can interact with ARF1 (ADP rybosilation factor), a protein that cycles between GTP 
(Guanosine-3-Phosphate) and GDP (Guanosine-2-Phosphate) bound state through the 
action of GAPs (GTPase Activating Protein) and GEFs (Guanine nucleotide Exchange 
Factors) (Goldberg, 1998) (Roth et al., 1999) (Menetrey et al., 2000) (Pasqualato et al., 
2001). ARFs is fundamental in regulating membrane recruitment of AP-4, a mechanism 
shared with AP-1 and AP-3 (Liang & Kornfeld, 1997) (Ooi et al., 1998) (Zhu et al., 1998) 
(Drake et al., 2000) but not with AP-2 that instead takes advantage of the binding with 
synaptotagmin for nucleation of endocytic clathrin-coated pits (Slepnev et al., 2000). The 
interaction between AP-4 and ARF1, differently from AP-3 and AP-1, does not occur through 
the β subunit but it is based on μ (nucleotide independent) and ε (when ARF1 is in the GTP 
bound state) subunits (Boehm et al., 2001). 
Moreover, an ENTH (Epsin-N-Terminal Homology) domain-containing protein, tepsin, was 
found to interact with AP-4 in a mass spectrometry screening and represents the only 
cytosolic protein found to be associated with the complex (Borner et al., 2012). This protein is 
similar to epsinR and CALM (Clathrin Assembly Limphoid Myeloid leukemia protein) that 
have been found associated with AP-1 and AP-2 complexes respectively. The interaction 
between AP-4 and tepsin, however, is very low at steady state, explaining the difficulty of 
observing it in immunoprecipitation experiment, but it becomes fundamental when vesicle 
formation is occurring. The interaction takes place on the appendage domain of ε and the C-
terminus of β4. This binding was also suggested to induce the clusterization of multiple AP-4 
complexes increasing the likelihood of AP-4 coat formation (Mattera et al., 2015). 
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AP-4, at least in epithelial cells, has been suggested to act as a sorting complex from the 
TGN to the basolateral compartment similarly to AP-1. However, a synthetic sequence 
(DLYYDPM) that is selectively bound by μ4 and not by other AP complexes was found to 
localise in the TGN and to accumulate in lysosomes when lysosomal inhibitor leupeptin was 
applied. This suggested that AP-4 can also mediate sorting from TGN to late endosomes-
lysosomes (Ruben et al., 2001). Another very recent paper demonstrated the interaction 
between AP-4 µ and the protein NAGPA, an enzyme that synthetizes mannose-6-phosphate 
signals that sort acid hydrolases to lysosomes strengthening the hypothesis of a role of AP-4 
in lysosomal degradation (Raza et al., 2015). 
Many different lines of evidence propose a role for AP-4 in neurons. AP-4 is expressed in 
neuronal cell lines (Dilaver et al., 2003) and in many regions of the brain (Yap et al., 2003). 
Burgos and colleagues have demonstrated that the direct binding of µ4 to Amiloyd Precursor 
Protein (APP) is necessary for its biosynthetic transport from the TGN to endosomes 
observing that depletion of AP-4 increases its TGN retention due to increased transient 
residence. This action of AP-4 has been suggested as protective from amyloid plaques 
formation as it removes APP from the site where γ-secretases produces Aβ peptide 
promoting instead caspase-cleavage and production of C31 non-pathogenic peptides 
(Burgos et al., 2010). 
In addition, AP-4 directly interacts through μ subunit with δ2 glutamate receptor, a receptor 
exclusively expressed in Purkinje cells of the cerebellum (Yap et al., 2003). δ2 glutamate 
receptor is fundamental for cerebellum functioning as knockout mice show motor learning 
impairment. In these cells, AP-4 is localised in soma and dendrites and in particular in Golgi 
region as shown by co-localisation with TGN38 and immunogold Electron Microscopy. The 
binding occurs through different motifs on the receptor: di-aromatic residues (FXF), 
phenylalanine-based motifs (FGSV) and FR motifs. 
A knockout (KO) mouse model of AP-4 β has been generated (Matsuda et al., 2008): these 
mice, despite showing a complete loss of the whole AP-4 complex, do not present any visible 
impairment, as they are viable, fertile, with normal gait and no anatomical defects. However, 
in the cerebellum of these animals AMPA receptors were observed in calbindin positive 
structures (axon marker) in the DCN (deep cerebellar nuclei) that receive projections from 
Purkinje cells suggesting an incorrect transport of these receptors. Electron microscopy 
analysis showed aberrant structures in the axons resembling autophagosomes, suggestion 
confirmed by the finding of increased LC3-II (microtubule-associated protein 1A/1B-Light 
Chain 3, phosphatidylethanolamine conjugated, an autophagosomes marker). These 
structures appear to contain AMPA receptors as demonstrated by co-localisation with LC3-II. 
Surprisingly no differences were found in somato-dendritic GluA1 and GluA2 levels and 
surface localisation. Overexpressed GluA1 was also mislocalised in hippocampal neurons 
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cultured from KOs. Similar mis-sorting effects were observed for other cargos of AP-4 such 
as δ2 glutamate receptor and LDLR (Low Density Lipoprotein Receptor) but not for mGluR1, 
Transferrin Receptor (TfR), NR1 (NMDA Receptor 1) that do not count on AP-4 for correct 
sorting. GluA1 and GluA2 are unable to bind directly μ4 but they are bound through TARPs 
(γ2 or stargazin, γ3, γ4 but not γ5) and at least γ3 was found mis-sorted in KO animals. This 
binding occurs at the C-terminal tail of TARPs at YRYRF motif. The authors thus 
hypothesized that, after AMPA-Rs are bound by TARPs at the Endoplasmic Reticulum, AP-4 
assembles at TGN or at some post Golgi compartment inducing correct somato-dendritic 
sorting of AMPA receptors. As some AMPA-Rs are present at presynapses they must 
escape AP-4 sorting possibly by phosphorylation of residues in the C terminal tail of TARPs 
(Matsuda et al., 2013). 
AP-4 importance in the brain is also suggested by the recent findings of AP-4 loss of function 
mutation in different patients affected by a complex set of symptoms, which has been named 
AP-4 deficiency syndrome (Verkerk et al., 2009) (Abou Jamra et al., 2011) (Moreno-De-Luca 
et al., 2011) (Kong et al., 2013) (Tuysuz et al., 2014) (Hardies et al., 2015) (Figure 9).  
 
 
Figure 9. Scheme representing the mutations found in the four subunits of AP-4 complex causative of AP-4 
deficiency syndrome (modified from (Hardies et al., 2015). 
 
This syndrome is characterized by microcephaly, muscular hypotonia that evolves to 
hypertonia, hyperreflexia, spastic paraplegia, inability to walk, severe cognitive deficit, 
marked speech delay, adaptive impairment, high palate, peculiar facial shape with wide 
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nasal bridge, short stature, hyperlaxity, genu recurvatum, pes planus or talipes equinovarus, 
waddling gait, stereotypic laughter, shy character. Epilepsy was observed in some cases. 
Neuroimaging techniques can show ventriculomegaly, hippocampal globoid formation, flat 
and thin hippocampus, thin splenium of corpus callosum and reduced white matter in 
temporal region. 
Interestingly, mutations on all subunits of AP-4 complex have been found to cause very 
similar phenotype as the loss of any of them will lead to the disruption of the complex and to 
degradation of the remaining subunits. Different types of mutation have been found such as 
nonsense and frameshift mutations that usually result in premature truncation of the protein. 
Very recently a variant of AP-4E1, encoding for the ε subunit, in heterozygosis, was found in 
individuals affected by stuttering (Raza et al., 2015).  
 
2.4 AMPA receptors 
This paragraph will provide a brief description of α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid or AMPA receptors as they are fundamental proteins for synapse 
assembly and functioning which trafficking to the plasma membrane is regulated by AP-4 
adaptor complex that we identified as TSPAN5 interactor.  
 
               
Figure 10. Illustration of A) AMPA-R heterotetramer in the membrane and of B) individual GluA subunit with the 
membrane domains in green, glutamate in its binding site in blue, Flip/Flop editing site in red and RNA editing 
Q/R site in yellow (Bassani et al., 2013). 
 
AMPA receptors are among the major glutamate receptors of the brain. They mediate most 
fast excitatory synaptic transmission thus being fundamental for correct brain functioning with 
specific roles in learning, memory and cognition. Since their discovery they have been 
extensively studied in many different models and their importance is now well established for 
what concerns basal transmission and for mechanisms of plasticity including Hebbian (both 
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Long Term Potentiation, LTP, and Long Term Depression, LTD) and homeostatic (referred 
as synaptic scaling). 
These ionotropic receptors are tetrameric complexes assembled from four subunits (GluA1-
4) (Traynelis et al., 2010) with GluA1-GluA2 and GluA2-GluA3 being the most expressed 
receptor in adult hippocampus and cortex (Craig et al., 1993).  
From a structural point of view all the subunits are composed of an N-terminal extracellular 
domain (ATD or NTD) followed by a ligand binding domain (LBD), three transmembrane 
domains (M1, M2 and M3), one re-entrant loop on the cytosolic side and an intracellular C-
terminal tail that presents the highest divergence between the four members (Figure 10) 
(Rosenmund et al., 1998) (Hollmann & Heinemann, 1994) (Dingledine et al., 1999).  
Membrane trafficking constitutes one of the main mechanisms of regulation of these 
receptors with two principal processes involved: removal (or endocytosis) and recycling. 
These events are strictly interconnected and we will analyse them with major focus on the 
recycling traffic as it mainly concerns the purpose of this study (Figure 11).  
 
      
Figure 11. AMPA-Rs membrane trafficking. The receptors are present at the PSD but they can escape laterally 
diffusing to presynaptic sites where they are endocytosed. The vesicles than reach the endosomal system that 
will direct them to lysosome for degradation or to recycling endosomes from where they exocytose in perisynaptic 
sites and then travel back to the PSD via lateral diffusion. Newly synthesized receptors travel from the ER/Golgi 
network via microtubules and then enter in the endosomal circuit for delivery. Many different interactors involved 
in these processes are depicted (Anggono & Huganir, 2012). 
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Two main factors affect AMPA-Rs trafficking: interacting partners and phosphorylation or 
other modifications; we will cite many proteins that can bind or modify AMPA-Rs and that are 
involved in these circumstances. 
 
2.4.1 AMPA-Rs endocytosis 
AMPA receptors removal is functionally related to LTD and to homeostatic response to 
sustained activation. It occurs through endocytosis mainly mediated by clathrin-coated pit.  
One of the first direct evidence that LTD plasticity induces AMPA-Rs endocytosis come from 
the observation of GluA2 tagged with pHluorin, a mutant GFP sensitive to pH that is 
fluorescent only in neutral pH while it is switched off in acidic pH that is found in all the 
intracellular vesicular compartments, endosomes included. In this condition, the stimulation 
of LTD through NMDA application induces a decrease in the signal arising from this construct 
suggesting a rapid endocytosis of GluA2 (Ashby et al., 2004). 
One of the major player that acts on AMPA-Rs endocytosis is AP-2, or adaptor protein 
complex 2, that we discussed earlier in this introduction. It is able to bind AMPA-Rs both 
directly and indirectly with stronger affinity through stargazin, one of the major TARPs, and to 
induce internalization of the receptors (Lee et al., 2002) (Kastning et al., 2007) (Matsuda et 
al., 2013). This event seems of particular importance in NMDA-induced LTD where AMPA-
Rs removal is one of the major system to reduce synaptic strength. The site of binding for 
AP-2 on AMPA-Rs was found to interact with another protein involved in receptors trafficking, 
NSF (N-ethylmaleimide Sensitive Fusion protein), an ATPase concurring to membrane 
fusion. The overlapping of the two binding sites produces the competition for AMPA-Rs 
binding between AP-2 and NSF with the latter being able to stabilize postsynaptic membrane 
preventing endocytosis (Beretta et al., 2005) (Araki et al., 2010). 
AP-3A adaptor was also involved in LTD, in fact it was demonstrated that it is part of a 
ternary complex with stargazin and AP-2. The formation of this complex is promoted by 
calcineurin phosphatase activation that dephosphorylates the C-terminus of stargazin. After 
AP-2 mediated internalization, AP-3A participates in directing AMPA-Rs to lysosomes for 
degradation (Matsuda et al., 2013). 
Another important player in AMPA-Rs endocytosis is PICK1 (Protein Interacting with C 
Kinase 1). This protein interacts with the C-terminus of AMPA-Rs with greater affinity when 
calcium ions increase, such as during LTD, and promote endocytosis (Hanley & Henley, 
2005). The phosphorylation of GluA2 on residue Serine 880 by PKC increases the binding of 
PICK1 that was also shown to stabilize AMPA-Rs in intracellular compartments after 
endocytosis (Lin & Huganir, 2007) (Hanley, 2008) (Citri et al., 2010).  
Phosphorylation and dephosphorylation of the C-terminal tail play a major role in receptor 
endocytosis with differences between the subunits: to simplify, it is predicted that GluA1 
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unphoshorylated state is more prone to endocytosis whereas GluA2 is preferentially removed 
from cell surface when it is phosphorylated. 
PICK1 is also able to inhibit Arp2/3 (Actin Related Protein 2 and 3) thus blocking actin 
polymerization that results in spine shrinkage, another important feature of LTD (Rocca et al., 
2008) (Nakamura et al., 2011). PICK1 is also regulated by a mechanism of competition, in 
fact, as described earlier in this introduction, it can be bound by TSPAN7 preventing the 
association with AMPA-Rs and thus blocking endocytosis (Bassani et al., 2012). 
Another player in GluA2 endocytosis is BRAG2 (Brefeldin-Resistant Arf-GEF 2), a guanine-
nucleotide exchange factor of the Arf-GEF family. Its binding to AMPA-Rs is enhanced by 
phosphorylation of tyrosine 876 and it promotes the recruitment of Arf 6, a protein involved in 
coat recruitment (Scholz et al., 2010). 
 
2.4.2 AMPA-Rs recycling 
Recycling is the process through which endocytosed receptors can be redirected to plasma 
membrane. This pathway is fundamental as it creates a pool of AMPA-Rs that are in close 
proximity with the postsynaptic membrane and thus ready to be exocytosed rapidly upon 
request. The events that require this pool of receptors are for example LTP and homeostatic 
up-scaling. From an experimental point of view it could be difficult to distinguish the recycling 
from the insertion of new receptors as they follow similar routes and are regulated by similar 
pathways; thus, we are going to deepen the recycling taking into account also mechanisms 
that have been proposed for newly synthesized receptors. 
In general, it is thought that LTP stimulates the membrane insertion of GluA1-GluA2 
receptors that would normally be excluded from synapses, whereas GluA2-GluA3 receptors 
traffic constitutively in and out the PSD. 
Newly synthetized receptors are thought to travel through vesicular transport mediated by 
either kinesin or dynein (Setou et al., 2002) (Perestenko & Henley, 2003) (Kapitein et al., 
2010). 
AMPA-Rs recycling is mainly mediated by the adaptor RAB11 (RAs-related protein in Brain 
11), which is indeed used as a marker for recycling endosomes, and requires MyosinVa or b 
motor that transports the vesicles to the plasma membrane on actin filaments routes (Correia 
et al., 2008) (Wang et al., 2008) (Stenmark, 2009). 
The exact site of exocytosis is still under investigation but the most accepted model 
hypothesizes that it would be out of the PSD in the perisynapse. The receptors then diffuse 
laterally on the membrane to reach the correct site where they are trapped by scaffolding 
proteins (Borgdorff & Choquet, 2002) (Ehlers et al., 2007) (Yudowski et al., 2007) (Heine et 
al., 2008) (Makino & Malinow, 2009). 
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However, the requirement of AMPA-Rs and the specific tetramers necessary for LTP are still 
matter of debate. Nevertheless, LTP generates an important entry of calcium that would 
activate a series of kinases such as CAMKII (Calcium/Calmodulin-dependent  protein Kinase 
II), PKC and PKA (Protein Kinase A) that can phosphorylate GluA1 (Lee, 2006) (Lisman et 
al., 2012). Many different residues of GluA1 can be phosphorylated: serines 816, 818, 831, 
845, 880 and threonine 840 (Barria et al., 1997) (Boehm et al., 2006) (Lee, 2006). For 
example, the protein 4.1N (protein 4.1 Neuronal) interacts with GluA1 with greater affinity 
when PKC phosphorylates Ser816 and 818 leading to the insertion of the receptor in the 
membrane (Shen et al., 2000) (Lin et al., 2009). An atypical PKC isoform, the PKMζ (a 
truncated form of PKCζ), increases AMPA-Rs levels, GluA2 in particular, at the surface 
membrane through NSF and its inhibition blocks the maintenance phase of LTP without 
affecting the induction (Yao et al., 2008). GRIP1/2 (Glutamate receptor interacting protein 1 
and 2) association with GluA2 is also regulated by phosphorylation (Kulangara et al., 2007); 
in fact, the phosphorylation of Ser880 decreases the affinity of this binding that is thought to 
be necessary for both delivery of newly synthesized receptors, through kinesin heavy chains 
binding (Wyszynski et al., 2002) (Shin et al., 2003) and recycling of internalized receptors 
through the interaction with NEEP21 (Steiner et al., 2005). The knockdown of either GRIP1 
or NEEP21 results in the accumulation of GLuA2 in early endosomes and lysosomes 
diminishing its surface expression and thus blocking LTP (Alberi et al., 2005). 
GRIP1 also interacts with GRASP-1 (GRIP-associated protein 1), an effector of RAB4 
expressed specifically in neurons, which regulates its association with recycling endosomes 
through syntaxin 13. The removal of GRASP1 also inhibits the late phase of LTP by reducing 
AMPA-Rs recycling (Ye et al., 2000) (Hoogenraad et al., 2010). 
Interestingly, in patients affected by autism, missense mutations of GRIP were found to 
cause faster recycling and increased surface expression of GluA2 (Mejias et al., 2011). 
NSF, which was already cited above in this introduction, is also a regulator of GluA2 insertion 
in surface membrane and it also act in its stabilization at synapses by competing with the 
binding of both AP-2 and PICK1. 
Exocytosis is also triggered in homeostatic synaptic up-scaling, that is when prolonged 
activity deprivation, for example by twenty-four hours bath application of TTX, produces 
recruitment of receptors and increase in currents to counterbalance the chronic inhibition. 
On one side, a major role has been attributed to calcium permeable AMPA-Rs, thus lacking 
GluA2 subunit, but the results are still under debate. It has been observed that TTX induces 
local synthesis of GluA1 from mRNA in dendrites by effect of retinoic acid signalling. The 
receptor then reaches the membrane in a pathway dependent on CAMKIIβ and 
phosphorylation at Ser845 of GluA1 itself (Goel et al., 2011) (Groth et al., 2011). On the 
other hand, many evidences support a role for GluA2 in synaptic scaling. For example, 
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knockdown of GluA2, or the overexpression of its C-terminal tail, was enough to block 
completely the scaling whereas knockdown or the C-terminus of GluA1 had no effect (Gainey 
et al., 2009). Moreover, also PICK1 was found to be released from GluA2/3 binding upon 
activity deprivation to increase its delivery to synapses (Anggono et al., 2011). 
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3. Materials and methods 
 
3.1 cDNA constructs 
The shRNA sequence for human TSPAN5 was obtained from (Dunn et al., 2010) and 
modified to knockdown the rat TSPAN5 mRNA (CAGGACAATTTAACCATTGTG). The 
Scrambled (SCR) sequence was designed using InvivoGen software available online 
(www.invivogen.com/sirnawizard/scambled.php) (GCAAATTCGTGTCGTATAACA). Both 
sequences were designed to be inserted in a short hairpin RNA and cloned into pLVTHM 
vector. As the shRNA targets specifically the rat sequence all the rescue experiments were 
performed co-expressing the human cDNA of TSPAN5. 
TSPAN5-GFP was a kind gift of Professor Eric Rubinstein (Dornier et al., 2012). TSPAN5 
sequence was sub-cloned into pMH4-SYN-tdimer2-RFP; gift of Dr R. Tsien. 
RAB4-GFP, RAB7-GFP and RAB11-GFP were kind gift of Professor Giampietro Schiavo. 
Neuroligin 1-AP and BirA-ER were kind gifts of Dr Olivier Thoumine. 
 
3.2 Cell cultures, transfection and lentiviral infection 
Human Embryonic Kidney 293FT cell line for generating lentivirus was grown in Dulbecco’s 
modified Eagle medium plus 10% fetal bovine serum, 1% penicillin/Streptomycin and 1% 
G418, an aminoglycoside antibiotic. Lentiviruses were prepared as by Lois and colleagues 
(Lois et al., 2002). Primary hippocampal neurons were prepared from embryonic rat (E18) 
brains (Brewer et al., 1993) and plated on coverslips coated with poly-L-lysine (0,25mg/ml) at 
75.000/well for immunochemistry and 300.000/well for biochemistry, co-immunoprecipitation 
and lentivirus infection. Cultured neurons were transfected using Lipofectamine 2000. 
Immature neurons were transfected or infected at DIV 5 and fixed or lysed at DIV 12 
whereas mature neurons were transfected at DIV12 and analysed at DIV18-20.  
 
3.3 Fractionation (PSD and Vesicles) 
To prepare synaptic plasma membrane fractions we used the protocol described by Perez-
Otano and colleagues (Perez-Otano & Ehlers, 2004). 
Rat cortices and hippocampi were homogenized in a buffer composed of 0.32M sucrose and 
HEPES 4mM, pH 7.4 plus protease inhibitor cocktail with a glass-teflon homogenizer on ice. 
All the following steps were performed at 4°C. The homogenate was then centrifuged at 
1000g for 10 minutes to isolate P1 fraction corresponding mainly to nuclei. The supernatant 
(S1) was further centrifuged at 10000g for 15 minutes. The resulting supernatant (S2) 
contains cytosol and light membranes. The pellet (P2), containing crude synaptosomes, was 
resuspended in the same HEPES/sucrose buffer and centrifuged again at 10000g for 15 
minutes to wash out contaminants. P2 fraction was then lysed with hypo-osmotic shock 
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adding 9 volumes of ice-cold H20 plus protease inhibitors and with a further homogenization 
in teflon-glass homogenizer. HEPES 1M was added to restore the initial concentration. 
Complete lysis was obtained by constant mixing for 30 minutes. 
The lysate was then centrifuged at 25000g for 20 minutes to remove the crude synaptic 
vesicles (S3). The pellet (P3) was resuspended in HEPES/sucrose buffer and loaded on a 
discontinue sucrose gradient made of three phases: 0.8, 1.0 and 1.2 M. The gradient was 
centrifuged at 150000g for 2 hours without break. The purified synaptic plasma membranes 
were collected from between 1.0 and 1.2 M layers. 2.5 volumes of 4mM HEPES were added 
to restore the initial sucrose concentration. 
The fraction was further centrifuged at 150000g for 30 minutes (Syn). To further separate the 
membranes the Syn fraction was resuspended in 50mM HEPES, 2mM EDTA, pH 7.4 plus 
protease inhibitor cocktail. Triton X-100 was added to a final concentration of 0.5% and the 
preparation was rotated for 15 minutes. 
A centrifugation at 32000g for 20 minutes yielded the PSD-1T fraction. This latter fraction 
was resuspended in 50mM HEPES, 2mM EDTA, pH 7.4. Triton X-100 was added at final 
concentration 0.5% to half of the preparation and it was rotated for 15 minutes and then 
centrifuged at 200000g for 20 minutes to collect the PSD-2T fraction. 
PSD-1T+S was obtained incubating the other half of the PSD-1T fraction with 3% sarcosyl 
for 10 minutes and centrifuging at 200000g for 1 hour. 
All the fractions were loaded on poly-acrylamide gels in equal volumes and underwent 
standard western blotting procedure. 
The fractionation of vesicles followed the protocol from Rao and colleagues (Rao et al., 
2011) with minor modifications. 
Briefly, crude synaptosomes were prepared as described above and lysed with hypo-osmotic 
shock with ice cold H20. The resulting vesicles were loaded on the top of a continuous 
gradient of sucrose (from 50mM to 1M) and centrifuged at 65000g for 3 hours at 4°C. Ten 
fractions of equal volume were collected from the top (Fraction 1) to the bottom (Fraction 10). 
Protein content was concentrated by precipitation with 6% trichloroacetic acid (TCA) and 
0.02 % sodium deoxycholate. 
All the fractions were loaded on poly-acrylamide gels in equal volumes and underwent 
standard western blotting procedure. 
 
3.4 BS3 crosslinking 
The experiments were carried out adapting the protocol from Boudreau and colleagues 
(Boudreau et al., 2012). Cultured neurons at different DIV were first washed with PBS 
supplemented with 0.1 mM CaCl2 and 1mM MgCl2 (PBS c/m). Non-membrane permeable 
BS3 cross-linker was added at 1mg/ml concentration in PBS c/m and incubated for 10 min at 
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4°C. The crosslinking was then quenched washing the  cells with 50mM glycine in TBS c/m. A 
final wash with TBS c/m removes the glycine. The cultures were then collected and lysed 
with mechanical homogenization in a buffer composed of 50mM Tris, 150mM NaCl, 1mM 
EDTA, 1% SDS, pH 7,4. The lysates were then loaded on acrylamide gel and underwent 
standard western blotting procedures to analyse GluA2/3, GluA1, TSPAN5, Stargazin, 
Tubulin and Transferrin receptor.  
 
3.5 Immunoprecipitation 
For immunoprecipitation experiments, cultured neurons and rat brains homogenates 
(homogenization buffer: 50mM TRIS-HCl, 200 mM NaCl, 1 mM EDTA or 0,1 mM CaCl2 and 
1mM MgCl2 pH 7.4, protease inhibitor cocktail supplemented with either 1%NP40 and 1% 
Triton X-100 or 1% Digitonin) were centrifuged at 10000 g for 30 min at 4°C and 
supernatants were incubated with appropriate antibodies at 4°C overnight. Protein A-agarose 
beads (Santa Cruz Biotechnology, US) were then incubated with homogenates at 4°C for 2 
hours. The beads were washed three times with lysis buffer, resuspended in 3X sample 
buffer and bound proteins were separated by SDS-PAGE. The following antibodies were 
used for immunoprecipitation: rabbit anti: -TSPAN5 (rabbit, SIGMA Aldrich), -GluA2 surface 
epitope (mouse, Millipore), -GluA2/3 (rabbit, gift of Prof. Gotti), -Stargazin (mouse, Millipore), 
-AP-4S1 (rabbit, gift of Prof. Hirst), -AP-4E (rabbit, gift of Prof. Hirst), -MyosinVa (rabbit, 
Sigma Aldrich). 
 
3.6 SDS-PAGE, western blot analysis 
Proteins were separated through SDS-PAGE on poli-acrilamyde gels and electro-blotted 
onto nitrocellulose membranes (GE Healtcare) in buffer containing 0.025 M Tris-HCl, 0.192 
M glycine, 20% methanol, SDS 0.05% at 400 mA for 120 min. Immunoblotting reactions were 
performed by incubating with the primary antibodies (RT, 2-3h in 5% milk TBS-Tween 0.1%)  
anti: -α tubulin (1:10000, mouse, SIGMA), -TSPAN5 (1:500, rabbit, SIGMA Aldrich), -GluA2 
(1:1000, mouse, NeuroMab), -GluA2 surface epitope (1:1000, mouse, Millipore), -GluA2/3 
(1:2000, rabbit, gift of Prof. Gotti), -GluA1 (1:1000, rabbit, Millipore), -AP-4S1 (1:250, rabbit, 
gift of Prof. Hirst), -AP-4E (1:500, rabbit, gift of Prof. Hirst), -Stargazin (1:500, mouse, 
Millipore), -Transferrin Receptor (1:1000, mouse, Invitrogen), -Neuroligin 1 (1:500, rabbit, 
Synaptic Systems), -EEA1 (1:500, mouse, Sigma Aldrich), -MyosinVa (1:500, rabbit, Sigma 
Aldrich), Rab11 (1:500, mouse, BD), -VGlut1 (1:500, rabbit, Synaptic Systems), -GFP 
(1:1000, rabbit, MBL). 
Horseradish peroxidase-conjugated anti-rabbit or anti-mouse antibodies (1:2000 GE 
Healtcare) were used as secondary antibodies (RT, 1h in 5% milk, TBS-Tween 0.1%). 
Immunoreactive bands were visualized by enhanced chemiluminescence (ECL, 
27 
 
PerkinElmer). Band intensity was measured using ImageJ and statistical analysis performed 
with GraphPad Prism 6 software. Data are expressed as mean ± SEM. 
 
3.7 Immunofluorescence, surface staining 
Cultured Hippocampal neurons were fixed either in 4% paraformaldehyde- 4% sucrose for 10 
minutes at 37°C or with methanol 100% for 10 minute s at -20°C and incubated with anti: -
TSPAN5 (1:50, rabbit, SIGMA Aldrich), -PSD-95 (1:400, mouse, NeuroMab), -GluA2 (1:200, 
mouse, NeuroMab), -GluA2 surface epitope (1:100, mouse, Millipore), -GluA2/3 (1:200, 
rabbit, gift of Prof. Gotti), -GluA1 (1:200, rabbit, Millipore), -Bassoon (1:100, mouse, 
Neuromab),) -AP-4S1 (1:100, rabbit, gift of Prof. Hirst), -AP-4E (1:100, rabbit, gift of Prof. 
Hirst) in GDB1X solution (2X: gelatin 0.2%, Triton X100 0.6%, 30mM Na2HPO4 pH 7.4, 0.9M 
NaCl) for 2 hours at room temperature. 
For surface staining, live DIV18-20 hippocampal neurons were incubated for 10 min at 37°C 
with anti GluA2 surface epitope antibody in culturing medium. After washing (PBS 
supplement with 1mM MgCl2 and 0.1 mM CaCl2), neurons were fixed for 10 minutes at room 
temperature in 4% paraformaldehyde/ 4% sucrose. 
Cells were then washed and incubated with Alexa 488 (1:400, Invitrogen), Alexa 555 (1:400, 
Invitrogen) or DyeLight-649 (1:200, Jackson Laboratories) coupled secondary antibodies 
anti-mouse diluted in GDB1X solution for 1 hour at room temperature.  
 
3.8 Membrane trafficking imaging assays (internalization and recycling) 
Internalization experiments were performed as by Bassani and colleagues (Bassani et al., 
2012). 
Neurons were incubated with the anti-GluA2 surface epitope antibody at 10 µg/ml in culture 
medium for 10 minutes at room temperature. The excess antibody was then removed by 
washing with PBS c/m. The antibody-bound receptors were then allowed to undergo 
internalization for 0, 5 or 10 minutes at 37°C. Aft er paraformaldehyde fixation, a secondary 
antibody labelled with AlexaFluor 555 was incubated in non-permeabilizing condition (PBS 
supplemented with 10% goat serum) for 1 hour at room temperature. After washing, the 
coverslips were incubated with a secondary antibody labelled with DyeLight-649 in 
permeabilizing condition (GDB1X) for 1 hour at room temperature. 
Recycling assay was adapted from the one of Raynaud and colleagues (Raynaud et al., 
2013). The antibody anti-GluA2 surface epitope was incubated as above but at 37°C to 
potentiate the internalization that was then allowed to occur for 30 minutes. To mask the 
antibody-bound receptor that was not internalized, a secondary antibody labelled with 
AlexaFluor 488 was incubated for 10 minutes at 37°C . The unlabelled, internalized, antibody-
bound receptor was then allowed to be recycled back to the surface of neurons for 0 or 10 
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minutes. After paraformaldehyde fixation the coverslips were incubated with secondary 
antibodies as described above. 
 
3.9 Image acquisition, quantification and statistical analysis 
Confocal images were obtained using a ZEISS LSM 510 Meta Confocal Microscope with a 
Nikon 63x objective with sequential acquisition setting at 1024x1024 pixels resolution. Each 
image was a ‘z’ series projection of approximately 7 to 12 images taken at 0.75 μm depth 
intervals. 
Transfected neurons were chosen randomly for quantification from two to ten coverslips from 
three to five independent experiments. 
Spine number, fluorescence intensity and co-localisation measurements were performed 
using NeuronStudio and ImageJ (Jacop plugin for co-localisation). Statistical comparisons 
were performed with appropriate statistical test using GraphPad Prism 6 software. Data are 
expressed as mean ± SEM. 
 
3.10 uPAINT 
uPAINT experiments for GluA2 were performed as by Giannone and colleagues (Giannone 
et al., 2010). Briefly, neurons transfected at DIV5 were put in an imaging chamber at DIV12 
in Tyrode’s buffer and mounted on an inverted microscope (model No. IX71; Olympus 
America, Melville, NY) equipped with a high 100X objective (NA . 1.4) and a charge-coupled 
device camera (Cascade 128; Roper Scientific, Princeton Instruments, Trenton, NJ). The 
setup used was the one available at the Bordeaux Imaging Center, part of the France-
BioImaging national infrastructure. 
Once a transfected neuron was found the anti-GluA2 antibody coupled to Atto-647 (gift of Dr 
Choquet) was added directly to the medium and rapidly resuspended. 
Registration of single phluorophores excited with a HeNe laser at tilted angle started when a 
sufficient number of molecules were visible and lasted for 4000 frames of 20ms (80s). 
Around four acquisitions per coverslip were collected. 
For Neuroligin-1 experiments, Neuroligin-1-AP, BirA-ER and either Scrambled or ShRNA-
TSPAN5 were transfected. Coverslips were mounted on the same instrument as above. In 
this case, the detection of surface molecule were possible adding monomeric Streptavidin 
coupled to Atto-594 (gift of Dr Thoumine) to the medium before starting the recording. 
The trajectories were analysed with a custom-made program (MATLAB, The MathWorks, 
Natick, MA) developed by Dr Sibarita through Metamorph. 
For both proteins, only the trajectories that last for more than 8 frames were considered for 
analysis. The optical resolution of this acquisition was 50 nm. For each molecule, the 
diffusion coefficient D was calculated and then plotted versus the percentage of molecule for 
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each D. Mean global diffusion coefficient was used for statistical comparison. 
 
3.11 Yeast Two-Hybrid Screening 
For Yeast two-hybrid experiments, a fragment corresponding to the TSPAN5 C-terminal tail 
(aa 254-268) was cloned in frame with the GAL4 DNA-binding domain (pGBKT7 vector), and 
used as bait to screen a human adult brain cDNA library (Clonetech, Mate and Plate Library). 
Positives clones (3+) grew on plates containing X-α-GAL and Aureobasidin A (QDO/X/A 
plates) and expressed all four integrated reporter genes: HIS3, ADE2, AUR1C and MEL1 
under the control of three distinct Gal4-responsive promoters. cDNA plasmids from positive 
clones were recovered via DH5a Escherichia coli (E.coli) transformation and plated on 
ampicillin plates and sequenced. 
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4. Results 
 
4.1 TSPAN5 localisation in brain suggests two distinct functions 
As so little is known about TSPAN5 in the brain we started evaluating its presence in 
different brain areas. We dissected adult mouse and rat brain separating hippocampus, 
cortex and cerebellum. By western blot, we were able to show that the protein is expressed 
broadly in the brain of both animals as it is present in all the three areas examined and in rat 
cultured hippocampal neurons (Figure 12 panel A). Moreover, the protein is present in its 
monomeric form (around 38 KDalton) and in aggregates of different molecular weights. 
We then wanted to analyse further the distribution of the protein inside the neurons and we 
thus performed immunofluorescence staining in cultured hippocampal neurons following the 
maturation of the cultures. We observed that the protein is present during all the phases of 
neuron maturation in culture being present already at DIV1 and still expressed at DIV18 
when the neurons are generally considered mature (Barnes & Polleux, 2009). 
A closer look at the staining suggested that the protein is broadly distributed in immature 
neurons (until DIV12) with a pattern that is suggestive of membrane localisation (Figure 12 
panel B, orange arrow). In mature neurons, instead, TSPAN5 becomes enriched in what 
resembles the perinuclear endoplasmic reticulum and in protrusions along the dendrites 
suggestive of dendritic spines (Figure 12 panel D, orange arrow). 
To confirm this hypothesis we performed BS3 crosslinking experiment at two developmental 
stages: DIV12 representative of immature neurons where synaptogenesis is starting and 
DIV18 when the neurons are mature and spiny (Figure 12 panel E). 
These experiments use BS3, a chemical crosslinker that is non-permeable to the membrane; 
in this way the treatment on live cultured neurons crosslinks only surface protein and after 
western blot analysis, it is possible to distinguish in the same gel lane between surface and 
intracellular protein as they have different molecular weights. 
We observed that the ratio of extracellularly facing versus total protein was higher at DIV12 
compared to DIV18 suggesting that the protein changes its localisation during neuronal 
maturation being mainly present on the surface of immature neurons while in mature stages 
it partially redistributes to intracellular compartments (Figure 12 panel E) (Extracellular/Total 
ratio: TSPAN5 DIV12 0,859±0,02, DIV19 0,670±0,04; N=3; *  p value = 0,0272, T-Test 
Mann-Whitney Post-hoc). Transferrin Receptor, used as control for surface proteins, 
maintains a stable configuration (Extracellular/Total ratio: TfR DIV12 0,474±0,19, DIV19 
0,511±0,21; N=3; NS  p value = 0,9043, T-Test Mann-Whitney Post-hoc). Tubulin was used 
as control of the non-permeability of BS3 and of homogeneity in protein amounts. 
We further analysed the mature localisation of TSPAN5 by separating postsynaptic densities 
from adult rat brain. TSPAN5 appears to be present in synaptosomes and in postsynaptic 
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density where PSD-95 is strongly enriched (Figure 12 panel F). Tubulin was present in all 
fraction whereas Synaptophysin, a presynaptic marker, disappears in the last fractions 
corresponding to PSD. 
Concordantly, we found that the protein co-localised with postsynaptic markers such as PSD-
95 and GluA2 in staining on mature cultured hippocampal neurons while it did it very little 
with presynaptic markers such as Bassoon, VGLUT1 (Vesicular GLUtamate Transporter 1) 
and VGAT (Vesicular GAba Transporter) (Figure 12 panel G) (Percentage of TSPAN5 co-
localising with: GluA2 85,0±10,2; PSD-95 87,4±4,2; Bassoon 28,0±8,8; VGLUT1 4,9±4,5; 
VGAT 7,5±5,7; N=10 for each condition). 
 
4.2 TSPAN5 regulates the formation of dendritic spines 
The presence of TSPAN5 on surface membranes of neuron dendrites at developmental 
stages when synaptogenesis peaks suggests that this protein could regulate the formation of 
dendritic spines. 
To investigate this point we designed a shRNA to knockdown the expression of this protein. 
The shRNA was tested by producing a lentivirus carrying the sequence and a GFP as 
reporter of the infection and compared to its Scrambled. The lentivirus infects the neurons 
and promotes the insertion of the sequences in random positions in the genome ensuring a 
stable expression of both the shRNA and the GFP. As observed in Figure 13 panel A the 
lentivirus was able to knockdown efficiently the level of the protein when applied to cultures 
for around five days in vitro (Figure 13 panel A). 
The Sh-TSPAN5 vector, or the one expressing its Scrambled sequence used as control, was 
transfected in neurons at DIV5, before synaptogenesis occurs, and the neurons were 
analysed at DIV20 when the majority of spines are physiologically formed. 
Figure 13 panel B and relative quantification show that, analysing only neurons that express 
the GFP as reporter of transfection, the number of dendritic spines was almost reduced to 
zero in condition of TSPAN5 silencing (Figure 13 panel B) (Dendritic spines density 
normalized to 1 for Scrambled: Scrambled 1±0,04, Sh-TSPAN5 0,04±0,02; N=10; *** p value 
< 0,0001; T-Test, Mann-Whitney post-hoc). 
In this experiment, dendritic spines were count using NeuronStudio software that 
automatically recognizes spines by their morphology visible thanks to cytosolic GFP 
expression. 
To further confirm this surprisingly strong effect we performed an immunocytochemical 
staining of a presynaptic (Bassoon) and of a postsynaptic (GluA2) protein to quantify the 
number of co-localising points, representative of synapses. As figure 13 panel C shows, the 
result was similar to the previous analysis (Number of co-localising points normalized to 1 for 
Scrambled: Scrambled 1±0,08, Sh-TSPAN5 0,06±0,01; N=10; *** p value < 0,0001; T-Test 
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Mann-Whitney post-hoc).  
We also observed that different postsynaptic markers were significantly reduced (PSD-95 
and GluA2) whereas presynaptic Bassoon has also a trend in reduction but not statistically 
significant, again strengthening the hypothesis of a main postsynaptic role of this protein 
(Figure 13 panel D) (Number of puncta normalized to 1 for Scrambled; Bassoon: Scrambled 
1±0,15, Sh-TSPAN5 0,4±0,24; N=10; NS; GluA2: Scrambled 1±0,11, Sh-TSPAN5 0,34±0,03; 
N=10; ** p value = 0,0061; PSD-95: Scrambled 1±0,25, Sh-TSPAN5 0,55±0,02; N=10; * p 
value=0,0286). 
The clear effect observed in these experiments strongly prompted us to investigate whether 
TSPAN5 could have a role directly in synaptogenesis and particularly in dendritic spines 
formation thanks to its predominantly postsynaptic localisation. 
 
4.2.1 TSPAN5 organizes TEMs that accommodate Neuroligin 1 and GluA2 
Since TSPAN5, as all the other members of the tetraspanin superfamily, is able to form 
Tetraspanin Enriched Microdomains and since TSPAN5 staining at immature stages is 
suggestive of the presence of the protein in clusters on the surface membrane, we wondered 
whether TEMs formed by TSPAN5 on neurons surface could be responsible of dendritic 
spine formation. 
Dendritic spine formation is a process that is still under debate but the most recent and 
accepted hypothesis is that upon contact between forming presynaptic bouton and growing 
postsynaptic filopodium the initial trans-synaptic interaction between Neurexin, on the 
presynapse, and Neuroligin 1, on the postsynaptic side, triggers the concentration of a 
variety of molecule on both sides. 
The protein that is thought to first concentrate is indeed Neuroligin 1 on the postsynapse; it 
would interact with the occurring Neurexins on the presynapse strengthening the adhesion 
between the two compartments.  
After that, PSD-95 localises in what will become the Postsynaptic Density and will stabilize all 
the receptors (AMPA-Rs, NMDARs…) and accessory proteins necessary for the correct 
functioning of mature synapses. A more detailed explanation of the process is provided in 
Chapter 2 Introduction, paragraph 2.2. 
We thus decide to investigate whether TSPAN5 TEMs could be the membrane scaffold that 
allows the stabilization of surface membrane proteins before the complete PSD complex is 
assembled. 
To verify this hypothesis we took advantage of the solubilisation characteristics and high 
cholesterol content of TEMs. 
The lysis with standard RIPA buffer, depleted of SDS, partially solubilizes Tetraspanins while 
lysis with a buffer containing digitonin 1% will lead to the precipitation of all cholesterol-
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enriched membranes such as TEMs. The centrifugation at 10000g for 20 minutes allows to 
separate soluble and insoluble component. 
As shown in Figure 14 panel A TSPAN5 is partially, if not almost completely, solubilized by 
RIPA as shown by the presence of the protein in the surnatant fraction and only very little in 
the pellet fraction. The opposite situation was obtained with digitonin; only very little amount 
of the protein was present in the solubilized fraction while the vast majority was in pellet. We 
decided to look first for Neuroligin 1 and secondly for GluA2/3, as representative of 
membrane proteins that concentrate in a second phase in the forming postsynapse. We 
observed that both proteins behaved in the same way as TSPAN5 while Transferrin receptor, 
used as a membrane protein not specifically concentrated in synapses, and Tubulin, used as 
cytosolic protein, had a much broader distribution in the different fractions (Figure 14 panel 
A; N=3).  
 
4.2.2 TSPAN5 stabilize Neuroligin-1 and GluA2 at the forming postsynapse 
To confirm that TSPAN5 TEMs concentrate Neuroligin 1 and AMPA-Rs we decided to verify 
whether the silencing of TSPAN5 could modify the solubility of these two proteins applying 
digitonin lysis as in the previous experiment.  
As expected by our hypothesis, the distribution of Neuroligin 1 and GluA2/3 was changed in 
favour of solubilized compartment upon knockdown of TSPAN5 suggesting that the 
membrane domains formed by TSPAN5 accommodate these proteins important for dendritic 
spine formation (Figure 14 panel B and C) (Supernatant/Pellet ratio normalized to 1 for 
Scrambled, GluA2/3: Scrambled 1±0,05, Sh-TSPAN5 0,65±0,10; N=5; * p value=0,013; 
Neuroligin 1: Scrambled 1±0,01, Sh-TSPAN5 0,75±0,10; N=4; * p value=0,048). Transferrin 
receptor and Tubulin, instead were not affected by TSPAN5 silencing (Figure 14 panel B and 
C) (Supernatant/Pellet ratio normalized to 1 for Scrambled, TfR: Scrambled 1±0,04, Sh-
TSPAN5 0,98±0,11; N=3; NS; Tubulin: Scrambled 1±0,03, Sh-TSPAN5 1,05±0,15; N=3; NS). 
As control, we verified by BS3 crosslinking that the total and the surface/total ratio of both 
proteins were unchanged in TSPAN5 silencing condition confirming that the effects observed 
were only due to redistribution of the proteins and not to reduced expression or degradation 
(Figure 14 panel D) (Neuroligin 1: Total/tubulin normalized to 1 for Scrambled, Scrambled 
1±0,11, Sh-TSPAN5 0,93±0,17; N=3; NS; Extracellular/Total ratio normalized to 1 for 
Scrambled, Scrambled 1±0,10, Sh-TSPAN5 0,96±0,13; N=3; NS; GluA2/3 Total/tubulin 
normalized to 1 for Scrambled, Scrambled 1±0,06, Sh-TSPAN5 1,11±0,07; N=3; NS; 
Extracellular/Total ratio normalized to 1 for Scrambled, Scrambled 1±0,22, Sh-TSPAN5 
1,06±0,18; N=3; NS). 
To strengthen this hypothesis we decided to use super-resolution microscopy in living 
neurons using a recently developed method named uPAINT (universal Point Accumulation 
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for Imaging in Nanoscale Topography). 
This method allows the visualization of freely moving molecules on the surface membrane 
and the quantification of their degree of mobility. (Giannone et al., 2013).  
We analysed the mobility of endogenous GluA2 receptor in DIV12 rat hippocampal neuron 
transfected at DIV5 either with the Scrambled shRNA, the Sh-TSPAN5, the Sh-TSPAN5 plus 
a TSPAN5-RFP insensible to the Sh-TSPAN5 (Rescue) or the TSPAN5-RFP construct 
alone, applying an antibody against an extracellular epitope of the receptor coupled to a 
molecule of Atto-647 fluorophore (Figure 15 panel A).  
Plotting the logarithm of diffusion coefficients (logD) versus the relative frequency of 
molecules moving with that coefficient, we obtained for GluA2 in Scrambled-shRNA two 
peaks, similarly to what observed by previous groups (Nair et al., 2013), corresponding to 
immobilized receptors when the logD was inferior to -1,6 and to mobile receptors when the 
logD was above -1,6 (Figure 15 panel B). These two populations correspond respectively to 
receptors residing in synapses and thus immobilized, and to receptors that are free to move 
on the membrane. Comparing our results with the one previously published by other groups 
(Nair et al., 2013) the balance was in favour of the mobile population of receptors in 
accordance with the fact that we analysed the mobility in younger neurons when the number 
of formed synapses is still much lower than in mature neurons.  
When we analysed the mobility of GluA2 in neurons where TSPAN5 was knocked down we 
observed a shift of the curve towards higher diffusion coefficients corresponding to a higher 
mobility of the receptors (Figure 15 panel B). Concordantly with this, the mean global 
diffusion coefficient of GluA2 receptor was significantly increased (Figure 15 panel C) (Mean 
Diffusion Coefficient: Scrambled 0,013±0,002 N=22, Sh-TSPAN5 0,025±0,004 N=21; * p < 
0,05; Rescue 0,008±0,001 N=18 ** p < 0,001 versus Sh-TSPAN5; Overexpression 
0,007±0,001 N=18; ** p < 0,001 versus Sh-TSPAN5; One-Way ANOVA Tukey’s Multiple 
Comparison)  as well as the ratio between the mobile and the immobile population (Figure 15 
panel D) (Mobile/Immobile Ratio: Scrambled 1,20±0,09 N=22, Sh-TSPAN5 1,6±0,12 N=21; * 
p value < 0,05; Rescue 1,04±0,08 N=18 ** p value < 0,01 versus Sh-TSPAN5; 
Overexpression 0,98±0,08 N=18 *** p value < 0,001 versus Sh-TSPAN5; One-Way ANOVA 
Tukey’s Multiple Comparison). 
When we co-expressed a shRNA insensitive TSPAN5-RFP together with the Sh-TSPAN5 we 
observed a reversal of the effect that was strong enough to produce an opposite variation on 
the mobility and mobile/immobile ratio. A similar effect was observed in neurons expressing 
the TSPAN5-RFP construct alone suggesting that the overexpression of TSPAN5, likely by 
increasing the number or the size of TSPAN5 formed TEMs, further stabilizes GluA2. 
We then wanted to verify if Neuroligin 1 behaved the same in this condition. Unfortunately, 
no highly specific antibody directed to extracellular epitope of the protein are available and 
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we were forced to use an approach based on overexpressing a tagged version of Neuroligin 
1 that presents an AP tag that is byotinilated by the bacterial enzyme BirA co-expressed in 
neurons (Chen et al., 2005). Once the two proteins are co-expressed, and thus the 
overexpressed Neuroligin 1 is byotinilated on the surface, it is possible to use an Atto-594-
coupled monomeric streptavidin to detect the protein and follow its mobility (Fig 15 panel E). 
Compared to GluA2, Neuroligin 1 did not show a two populations behaviour while instead a 
single peak was detected. When TSPAN5 expression was silenced, the curve was once 
again shifted to higher diffusion coefficients (Figure 15 panel F) and the global diffusion 
coefficient was significantly higher than the one in Scrambled condition (Figure 15 panel G) 
(Mean Diffusion Coefficient: Scrambled 0,011±0,0009 N=18, Sh-TSPAN5 0,023±0,0048 
N=18; * p value =  0,0192; T-Test Mann-Whitney post hoc). 
This result suggests that also Neuroligin 1 can be trapped and stabilized inside TSPAN5 
TEMs. Unfortunately, we weren’t able to analyse the behaviour of Neuroligin 1 in Rescue and 
Overexpression as the RFP signal of TSPAN5-RFP construct would have masked and 
biased the detection of Atto-594 molecules. We are planning to implement the analysis of 
Neuroligin 1 mobility in these two conditions by using a bi-cistronic vector expressing either 
TSPAN5 with a GFP reporter alone or together with the Sh-TSPAN5. 
All these results together strongly suggest that TSPAN5 assembles in membrane domains 
that are responsible of the formation, or stabilization, of dendritic spines in cultured rat 
hippocampal neurons. 
Our findings propose that TEMs formed by TSPAN5 are able to stabilize Neuroligin 1 and 
GluA2 and to trap or at least slow down their free movements in the membrane increasing 
the likelihood of transynaptic interaction and intrasynaptic stabilization (Figure 16). 
 
4.3 TSPAN5 regulates GluA2 recycling 
4.3.1 TSPAN5 interacts with AP-4 and GluA2 
As we hypothesized two different functions for TSPAN5 at different developmental stages, 
after having characterized the one during synaptogenesis, we wanted to deepen the role of 
this protein in mature neurons. As from our first experiments, we have found that this second 
activity was likely taking place in some membranous intracellular compartment, we decided 
to look for interactors on the intracellular side. We thus used the C-terminal tail of the protein 
to perform a yeast two-hybrid screening against an adult human brain cDNA library finding 
different interesting interactors. We decided to focus our attention on AP-4σ, a subunit of the 
Adaptor Protein Complex 4, an obligate tetrameric association of four proteins (AP-4ε, AP-
4β, AP-4μ, AP-4σ) belonging to the family of Adaptor Proteins that also counts the more 
famous AP-1 and AP-2 all involved in vesicular trafficking (Figure 17 panel A). 
Little is known on this protein and more details can be found in Introduction paragraph 2.3. 
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AP-4 is currently thought to traffic proteins cargo from the Trans Golgi Network to the 
endosomal compartment and it has been involved in sorting of AMPA-Rs to dendritic 
compartment through its binding with Stargazin, one of the TARP (Transmembrane AMPA 
receptor Regulatory Protein) very well known for its role in regulating stabilization, trafficking 
and dynamics of AMPA-Rs. 
We were thus interested in understanding whether TSPAN5 could also be involved in AMPA-
Rs trafficking and consequently in synapses functioning. 
We reconfirmed the interaction of TSPAN5 with AP-4σ in immunoprecipitation experiments 
performed in lysates of rat hippocampi (Figure 17 panel B). We detected AP-4 σ and ε when 
we immunoprecipitated TSPAN5 with a specific antibody and we were also able to find 
TSPAN5 when we performed immunoprecipitation with anti AP-4σ or ε antibodies. 
As it is already known that AP-4 complex is able to bind GluA2 through Stargazin we looked 
for this AMPA-R in immunoprecipitates of TSPAN5. We were able to detect GluA2 in 
immunoprecipitates for TSPAN5 in adult rat hippocampi lysates in HEPES-EDTA buffer, 
known to fluidify membrane, and after -80 freezing to destroy Tetraspanin Enriched 
Microdomains thus detecting only specific direct interactions (Figure 17 panel C).  
 
4.3.2 Silencing of TSPAN5 reduces GluA2 and Stargazin 
We were then interested in analysing if the knockdown of TSPAN5 could somehow influence 
GluA2 and Stargazin expression, especially on surface membrane considering the known 
role of Stargazin in trafficking and stabilization of AMPA-Rs. 
We decided to perform BS3 crosslinking experiments in hippocampal neurons infected with a 
lentivirus carrying either the Scrambled-shRNA or the Sh-TSPAN5 and analysed via 
standard western blotting the expression on the surface of GluA2/3, Stargazin and GluA1 
(Figure 18 panel A). Transferrin was analysed as control for surface proteins, tubulin for 
cytosolic proteins and GFP was used as control for efficient infection. 
We found that GluA2 was strongly reduced both in total amount and in the surface/total ratio 
demonstrating an impairment of trafficking or stabilization of the protein on the surface with a 
likely consequent degradation of mis-localised receptors (Fig 18 panel B) (Total/Tubulin 
Ratio: GluA2/3, Scrambled 1±0,03, Sh-TSPAN5 0,43±0,01; N=4; *** p value < 0,001; 
Transferrin Receptor, Scrambled 1±0,1, Sh-TSPAN5 1,02±0,06; N=4; NS; Extracellular/Total 
Ratio: GluA2/3, Scrambled 1±0,01, Sh-TSPAN5 0,61±0,02; N=4; *** p value < 0,001; 
Transferrin Receptor, Scrambled 1±0,06, Sh-TSPAN5 1,02±0,06; N=4; NS; T-Test Mann-
Whitney Post-Hoc). 
However, GluA1 signal was not reduced, but instead showed an increase in the surface/total 
amount, probably due to an attempt of the cells to counteract the loss of GluA2 receptors 
(Total/Tubulin Ratio: GluA1, Scrambled 1±0,01, Sh-TSPAN5 1,32±0,02; N=3; * p value; 
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Extracellular/Total Ratio: GluA1, Scrambled 1±0,01, Sh-TSPAN5 1,4±0,11; N=3; * p value = 
0,0278; T-Test Mann-Whitney Post-Hoc).  We also detected a small decrease of Stargazin 
only on the surface with no total protein amount differences and this is in accordance with the 
role of Stargazin on all AMPA-Rs and not only on GluA2 subunit containing ones 
(Total/Tubulin Ratio: Stargazin, Scrambled 1±0,15, Sh-TSPAN5 1±0,10; N=4; NS; 
Extracellular/Total Ratio: Stargazin, Scrambled 1±0,06, Sh-TSPAN5 0,67±0,09; N=4; * p 
value=0,0285; T-Test Mann-Whitney Post-Hoc). 
This result could represent that the mechanism observed is specific for GluA2 subunits of 
AMPA-Rs. 
We were able to confirm the reduction of GluA2 on the surface also by surface 
immunostaining on hippocampal neurons transfected with Scrambled-shRNA or Sh-TSPAN5 
(Figure 18 panel C) (Number of puncta/ area normalized to 1 for Scrambled; GluA2 
Scrambled 1±0,12, Sh-TSPAN5 0,75±0,05; N=10; * p value = 0,033; T-Test Mann-Whitney 
post hoc). 
As no good antibody for surface labelling were available for GluA1 we performed a standard 
immunocytochemistry protocol and reconfirmed the increase in GluA1 (Figure 18 panel C) 
(Number of puncta/ area normalized to 1 for Scrambled; GluA1 Scrambled 1±0,08, Sh-
TSPAN5 1,59±0,17; N=10; ** p value = 0,0091; T-Test Mann-Whitney post hoc.  
We also checked the effect of TSPAN5 silencing on dendritic spines number in mature 
neurons, as we have observed a fundamental role of TSPAN5 in its formation. We found a 
significant decrease in spine density but less pronounced than the one obtained when the 
protein was knocked down before the peak of synaptogenesis (Figure 18 panel D) (Spine 
Density normalized to 1 for Scrambled: Scrambled 1±0,05, Sh-TSPAN5 0,63±0,03; N=8; *** 
p value < 0,001; T-Test Mann-Whitney post-hoc). This reduction could be due to different 
effects: one it could be that the important role of TSPAN5 in spines formation would be 
affecting also the continuous renovation of dendritic spines that occurs also at mature 
stages; the second could be that the reduction in GluA2 is affecting spine stability. 
Unfortunately, we cannot exclude one or the other effect. 
 
4.3.3 TSPAN5-induced GluA2 reduction is due to lysosomal degradation 
We then wanted to deepen the mechanism through which GluA2 appears to be reduced. The 
most likely hypothesis would be that receptors that are somehow perturbed in their trafficking 
or in stabilization at synapses and thus retained intracellularly would then be degraded to 
avoid excessive accumulation. 
Two are the main degradation pathways for proteins in the cells: the proteasome or the 
lysosomes. We thus decided to block these two pathways and look for GluA2. Using MG132, 
we blocked proteasome and then analysed GluA2/3 via immunostaining in neurons 
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transfected with Scrambled-shRNA or Sh-TSPAN5 (Figure 19 panel A and B). As appears by 
the quantification of total amount of GluA2/3, MG132 was able to increase receptors amount 
in Scrambled condition and in Sh-TSPAN5. However, the increase in this latter condition was 
not sufficient to reach the level of the treated Scrambled-shRNA suggesting that proteasome 
was not involved in this degradation (Mean Intensity normalized to 1 for Scrambled DMSO: 
Scrambled DMSO 1±0,07 N=6, Scrambled MG132 1,63±0,03 N=6, Sh-TSPAN5 DMSO 
0,66±0,11 N=6, Sh-TSPAN5 MG132 1,27±0,06 N=6; Scr DMSO vs Scr MG132 *** p value < 
0,001; Scr DMSO vs Sh-TSPAN5 DMSO * p value < 0,05; Sh-TSPAN5 DMSO vs Sh-
TSPAN5 MG132 *** p value < 0,001; Scr MG132 vs Sh-TSPAN5 MG132 * p value < 0,05; 
One way ANOVA Holm-Sidak Multiple comparison). We thus decided to verify whether the 
lysosomal pathway could be responsible of this degradation. 
In fact, as GluA2 is a transmembrane protein it will always reside in vesicles for each step of 
the trafficking making lysosomal degradation to be more likely involved in this process.  
As expected, the treatment with leupeptin, a specific lysosomal blocker, was able to rescue 
the levels of GluA2/3 in Sh-TSPAN5 almost completely to the levels reached by the treated 
control Scrambled-shRNA (Figure 19 panel C and D) (Mean Intensity normalized to 1 for 
Scrambled H20: Scrambled H20 1±0,04 N=6, Scrambled Leupeptin 1,39±0,09 N=6, Sh-
TSPAN5 H20 0,69±0,03 N=6, Sh-TSPAN5 Leupeptin 1,30±0,06 N=6; Scr H2O vs Scr 
Leupeptin ** p value < 0,01; Scr H2O vs Sh-TSPAN5 H2O * p value < 0,05; Sh-TSPAN5 
H2O vs Sh-TSPAN5 Leupeptin *** p value < 0,001; Scr Leupeptin vs Sh-TSPAN5 leupeptin 
NS; One way ANOVA Holm-Sidak Multiple comparison). 
 
4.3.5 TSPAN5 is localised in recycling endosomes 
We demonstrated that TSPAN5 silencing causes a reduction of GluA2 receptors on the 
surface inducing an increased degradation via lysosomes. 
We have shown that in mature neurons there is an increase in the level of TSPAN5 in 
intracellular compartment and that this protein can interact with AP-4 complex that is known 
to be involved in intracellular vesicles trafficking. 
All these results support the hypothesis that TSPAN5 can be involved in the stabilization or in 
the sorting of GluA2 receptors in some intracellular vesicles. 
To understand further which of the numerous types of vesicles could be involved in these 
processes we decided to perform a vesicle fractionation from rat brain hippocampi and 
cortices. We prepared crude synaptosomes and lysed them with hypo-osmotic shock to 
release the intracellular content that was then loaded on top of a linear gradient of sucrose. 
Equal volume fractions were then collected and protein content was precipitated with Sodium 
Deoxycholate and Trichloroacetic acid and analysed by standard western blotting. 
The fractions were characterized using different proteins as markers: EEA1 (Early 
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Endosomes Associated protein 1) marks early endosomes, VGLUT1 synaptic vesicles, 
Transferrin Receptor and RAB11 mark the recycling endosomes. When we analysed 
TSPAN5 we found a distribution very similar to the one of Transferrin Receptor and RAB11 
strongly suggesting that this protein could reside in recycling endosomes vesicles (Figure 20 
panel A). 
To confirm this result we transfected DIV14 hippocampal neurons with either RAB4-GFP, 
RAB7-GFP or RAB11-GFP, as markers respectively for early, late and recycling endosomes, 
and immunostained for TSPAN5 (Figure 20 panel B). We found high level of co-localisation 
with all the three GFP tagged RABs as expected by the fact that TSPAN5 is a membrane 
protein and would pass through all this vesicles for its localisation and processing. However, 
a significantly higher co-localisation was found between TSPAN5 and RAB11-GFP 
strengthening the hypothesis that this protein mainly resides in recycling endosomes in 
mature hippocampal neurons (Figure 20 panel C) (Mander’s Co-localisation index; RAB-4 
0,76±0,02 N=5; RAB-7 0,79±0,06 N=5; RAB11 0,94±0,01 N=5; RAB-11 vs RAB-4 * p value < 
0,05; RAB-11 vs RAB-7 * p value < 0,05; One-Way ANOVA Tukey’s multiple comparison). 
To further validate these results we performed an immunoprecipitation on rat brain 
hippocampi and cortices, lysed in digitonin 1% to remove TEMs, and found that TSPAN5 and 
GluA2/3 were associated with MyosinVa, a motor protein known to be involved in the 
transport of recycling endosomes to membrane surface (Figure 20 panel D). 
 
4.3.6 TSPAN5 regulates GluA2 recycling 
Once assessed that TSPAN5 resides in recycling endosomes and as this organelles are 
important to maintain the correct amount of GluA2 receptors on the surface, we decided to 
verify whether TSPAN5 could have a role in this process. 
We used an antibody feeding assay to measure the recycling of the receptor: an anti GluA2 
antibody was given in living hippocampal neurons transfected either with Scrambled-shRNA, 
Sh-TSPAN5 or shRNA plus TSPAN5-GFP and we left 30 minutes to the antibody to be 
internalized. After that, the antibody that was bound to receptor that did not internalize was 
bound to a secondary antibody coupled to Alexa-488 in excess. 0 or 10 minutes were given 
to the internalized receptor-antibody complex to recycle back to the surface. A secondary 
antibody bound to Alexa-555 was given after fixation in non-permeabilizing condition followed 
by a third secondary antibody bound to DyeLight 649 in permeabilizing condition (Figure 21 
panel A). The ratio between the Alexa-555 signal and the sum of Alexa-555 and DyeLight 
649 signals gives the amount of extracellular receptor that, given the experimental design, 
would be only the recycled one. 
In this condition, we observed that with the Scrambled-shRNA in 10 minutes there was a 17 
percent increase in the surface signal that was completely lost in Sh-TSPAN5. This 
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demonstrates that the removal of TSPAN5 leads to an almost completely disruption of this 
process. The concomitant overexpression of an shRNA insensitive TSPAN5-GFP restored 
completely the effect guaranteeing that we were not observing an unspecific effect of the Sh-
TSPAN5 (Figure 21 panel B) (Extracellular/Total Mean intensity normalized to 1 for 
Scrambled 0’: Scrambled: 0’ 1±0,05 N=18; 10’ 1,17±0,03 N=18; Sh-TSPAN5: 0’ 0,97±0,05 
N=12; 10’ 0,92±0,04 N=12; Rescue: 0’ 1,08±0,03 N=12; 10’ 1,14±0,03 N=12; Scrambled 0’ 
vs 10’ * p value < 0,05; Sh-TSPAN5 0’ vs 10’ NS; Scrambled 10’ vs Sh-TSPAN5 10’ ** p 
value < 0,01; Rescue 10’ vs Sh-TSPAN5 10’ * p value < 0,05; One-Way ANOVA Tukey’s 
multiple comparison). 
To assess that the effect observed was not biased by any impairment in the internalization of 
GluA2, we used an antibody feeding assay and verified that no differences were present in 
the internalization rate of GluA2 in TSPAN5 silencing condition (Figure 21 panel C and D) 
(Intracellular/Total Mean intensity normalized to 1 for Scrambled 0’: Scrambled: 0’ 1±0,02 
N=5; 5’ 1,09±0,01 N=5; 10’ 1,05±0,03 N=5; Sh-TSPAN5: 0’ 0,97±0,02 N=5; 5’ 1,07±0,03 
N=5; 10’ 1,01±0,04 N=5; Scrambled 0’ vs 5’ * p value < 0,05; Scrambled 0’ vs 10’ NS; Sh-
TSPAN5 0’ vs 5’ * p value < 0,05; Sh-TSPAN5 0’ vs 10’ NS; Scrambled 0’ vs Sh-TSPAN5 0’ 
NS; Scrambled 5’ vs Sh-TSPAN5 5’ NS; Scrambled 10’ vs Sh-TSPAN5 10’ NS; T-Test 
Mann-Whitney post hoc). 
All these experiments suggest that TSPAN5 in mature neurons is able to regulate GluA2 
recycling through the binding of AP-4 complex (Figure 22). 
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Figure 12. TSPAN5 is expressed in mammalian brain and presents different 
localisation depending on neuronal developmental stage: A) Western blot showing 
TSPAN5 expression in brain lysates from Rattus Norvegicus and Mus Musculus. 
Cerebellum, Cortex and Hippocampus were analysed. The protein is present in its 
monomeric form (around 38 KDa) and in aggregates of different sizes. B, C, D) TSPAN5 
immunofluorescence on cultured hippocampal neurons from DIV1 to DIV18. B) TSPAN5 at 
DIV6 is accumulated in filopodia extension (orange arrow, right panel) and in plasma 
membrane where it forms aggregates reminders of Tetraspanin Enriched Microdomain 
(orange arrow, left panel C). At DIV11 TSPAN5 starts to localise in forming dendritic spines 
(orange arrow, right panel D). In mature neurons (DIV18) TSPAN5 is almost completely 
concentrated in dendritic spines (orange arrow, left and right panel). E) BS3 crosslinking 
experiments on cultured hippocampal neurons at two different developmental stage. Western 
blots show TSPAN5, Transferrin Receptor and Tubulin. The quantification shows the ratio 
between extracellular and total signal and demonstrated that TSPAN5 is highly enriched on 
the surface in immature neurons while it tends to relocalise to intracellular compartment in 
mature neurons. F) Post Synaptic Density fractionation on adult rat brain hippocampi and 
cortices. Western blot shows the enrichment of PSD95 in the last fractions corresponding to 
the PSD whereas synaptophysin disappears, as it is a presynaptic component. TSPAN5 is 
present in the synaptosomes and in the PSD 2-T suggesting a postsynaptic localization. 
(Tot=Total homogenate, P1=fraction corresponding mainly to nuclei, S1=fraction 
corresponding to cytosol, P2=crude synaptosomes, S2= cytosolic membranes, Syn=purified 
synaptosomes, PSD-1T= postsynaptic density fraction extracted with Triton X-100, PSD-2T= 
PSD-1T re-extracted with Triton X 100, PSD-1T+S= PSD-1T extracted with sarcosyl). G) 
TSPAN5 immunofluorescence on DIV20 cultured hippocampal neurons together with GluA2 
and PSD95 as postsynaptic markers, Bassoon as presynaptic marker and VGLUT and 
VGAT as presynaptic vesicular markers for excitatory and inhibitory synapses respectively. 
Scale bars are 20 μm. The graph shows the percentage of TSPAN5 colocalising with each of 
the analysed markers suggesting the preponderant postsynaptic localisation. 
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Figure 13. TSPAN5 silencing dramatically reduces the number of dendritic spines: A) 
Test for the Sh-TSPAN5 silencing. A lentivirus carrying the sequence was produced and 
cultured hippocampal neurons were infected at DIV5 with increasing amount of the virus and 
TSPAN5 was quantified by western blotting at DIV20. The graph shows that with a 10µl 
lentivirus suspension is possible to obtain an 80% reduction of the protein. B) Cultured 
hippocampal neurons were transfected either with the Sh-TSPAN5 or with its Scrambled 
ShRNA at DIV5 and analysed at DIV20 for dendritic spine density. The images and the graph 
show that TSPAN5 silenced neurons are almost completely deprived of dendritic spines. 
Scale bars are 20µm. C) Immunofluorescence analysis of GluA2 and Bassoon on neurons 
transfected as in panel B. The number of colocalising puncta between the two markers was 
taken as an indicator of the number of synapses. The images and the graph shows that also 
in this case TSPAN5 silencing almost completely removes synapses from transfected 
neurons. D) Immunofluorescence analysis for GluA2 and PSD95 as postsynaptic markers 
and for Bassoon as presynaptic marker in neurons transfected as in panel B and C. The 
images and the graph show that the removal of TSPAN5 significantly decreases the number 
of puncta for both GluA2 and PSD95 but not for Bassoon suggesting that the effect was 
mainly postsynaptic. 
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Figure 14. TSPAN5 TEMs accommodate Neuroligin 1 and GluA2: A) Neurons at DIV12 
were lysed either in standard RIPA buffer or in a buffer with Digitonin 1% and then 
centrifuged. The western blot showed that TSPAN5 is solubilized in RIPA while it becomes 
completely insoluble in Digitonin 1% due to the cholesterol enriched nature of TEMs. 
Neuroligin 1 and GluA2 follow the same behaviour suggesting their presence in TEMs. 
Conversely, Transferrin Receptor and Tubulin have a much broader distribution. B, C) 
Hippocampal neurons infected either with Scrambled or Sh-TSPAN5 carrying lentivirus and 
lysed in digitonin 1%. Western blots and graph show that TSPAN5 silencing induces 
increased solubility of Neuroligin 1 and GluA2/3 demonstrating that they are relocalised to 
lighter membranes. Transferrin receptor and tubulin were not affected. GFP serves as control 
of infection. D) BS3 crosslinking experiments on cultured hippocampal neurons at DIV12 
infected either with Scrambled or Sh-TSPAN5 lentivirus at DIV5. Western blots and their 
relative quantifications demonstrated that neither Neuroligin 1 nor GluA2/3 amount as total or 
extracellular/total ratio are changed upon TSPAN5 silencing. 
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Figure 15. TSPAN5 regulates GluA2 and Neuroligin 1 lateral mobility. A) Widefield 
images of DIV12 cultured hippocampal neurons transfected at DIV5 with either Scrambled-
shRNA, Sh-TSPAN5, Sh-TSPAN5 plus TSPAN5-RFP (Rescue) or TSPAN5-RFP 
(Overexpression) and relative representations of GluA2 trajectories obtained by super 
resolution imaging of anti-GluA2 antibodies coupled to Atto-647. B) Plot showing the 
logarithm of the diffusion coefficient of GluA2 and the relative frequency for the condition 
described in panel A. The black dotted line at logD -1.6 represents the separation between 
immobilized (<1.6) and mobile receptors (> 1.6). C) Quantification of the mean diffusion 
coefficient of GluA2 for the condition described in panel A showing the increased mobility of 
the receptor upon TSPAN5 silencing and its decrease upon TSPAN5 rescue and 
overexpression. D) Quantification of the Mobile/Immobile ratio of GluA2 showing the shift in 
favour of mobile receptor in absence of TSPAN5 and of immobile receptor upon TSPNA5 
rescue and overexpression. E) Widefield images of DIV12 cultured neurons transfected at 
DIV5 with Neuroligin 1-AP and BirA-ER and either Scrambled-shRNA or Sh-TSPAN5 and 
relative representation of Neuroligin 1 trajectories obtained by super resolution imaging of 
monomeric Streptavidin coupled to Atto-594. F) Plot showing the distribution of the logarithm 
of diffusion coefficient of Neuroligin 1 in the condition described in panel E. G) Quantification 
of the mean diffusion coefficient of Neuroligin 1 for the condition described in panel E 
showing the increased mobility of Neuroligin 1 in absence of TSPAN5. 
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Figure 16. TSPAN5 regulates dendritic spine formation promoting the clusterization of 
Neuroligin 1 and GluA2 receptor. Schematic model representing the hypothesis of our 
work. The first signal of dendritic spine formation occurs upon contact between a dendritic 
filopodium and a forming presynapse through the binding of Neuroligin 1 and Neurexin. 
TSPAN5 formed TEMs localizes in the site of this interaction and favours the clusterization of 
more Neuroligin 1 that can interact with the occurring Neurexins to strengthen the trans-
synaptic adhesion. AMPA receptors are also accumulated in the same site to make the 
synapse functional. 
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Figure 17. TSPAN5 interacts with AP-4 and GluA2. A) Table representing the results 
obtained in Yeast Two-Hybrid Screening. Both the full length and the C-terminal tail of 
TSPAN5 produces more than 3 positive clones with AP-4 σ subunit. B) Co-
immunoprecipitation experiment on adult rat hippocampi and cortices lysed in RIPA buffer. 
The immunoprecipitation of TSPAN5 co-immunoprecipitates AP-4 σ and as the complex is 
obligated also AP-4 ε. Accordingly, both the immunoprecipitation of AP-4 σ and AP-4 ε co-
immunoprecipitates TSPAN5. C) Co-immunoprecipitation experiment on adult rat hippocampi 
and cortices lysed in a buffer containing HEPES-EDTA and after -80°C freezing. The 
immunoprecipitation of TSPAN5, AP-4 σ and AP-4 ε co-immunoprecipitate GluA2/3 receptor. 
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Figure 18. TSPAN5 silencing specifically decreases GluA2 AMPA receptor subunit. A) 
BS3 crosslinking experiment on DIV18 cultured hippocampal neurons infected at DIV12 with 
either a lentivirus carrying the Scrambled-shRNA or the Sh-TSPAN5. Western blots analysed 
GluA2/3, Stargazin and GluA1. Transferrin receptor was used as control for surface protein, 
tubulin for cytosolic and to normalize the amount of protein loaded and GFP was a control of 
infection. B) Relative quantifications show that TSPAN5 silencing strongly reduces GluA2/3 
both in its total and surface amount whereas Stargazin was reduced only in the surface. 
GluA1 instead was increased in both total and surface amounts. Transferrin receptor was not 
affected. C) Immunostaining for surface GluA2 and total GluA1 receptor in DIV20 cultured 
hippocampal neurons transfected at DIV12 with either the Scrambled-shRNA or the Sh-
TSPAN5. The images and the relative quantification show that the amount of GluA2 receptor 
on the surface was reduced upon TSPAN5 silencing. GluA1 signal instead was increased 
when TSPAN5 was removed. D) Quantification of dendritic spine density in DIV20 cultured 
hippocampal neurons transfected at DIV12 with either the Scrambled-shRNA or the Sh-
TSPAN5 showing a significant reduction in the number of spines upon TSPAN5 silencing. 
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Figure 19. TSPAN5 silencing-induced GluA2 reduction is due to lysosomal 
degradation. A) Immunostaining for GluA2/3 on DIV20 cultured hippocampal neurons 
transfected at DIV12 with either Scrambled-shRNA or Sh-TSPAN5 and treated for 90 
minutes with either DMSO or 10μM MG132 as proteasome inhibitor. Scale bars are 20 μm B) 
Relative quantification showing that MG132 increases the amount of GluA2/3 in both 
Scrambled and Sh-TSPAN5 condition. However, the increase in latter condition was not 
sufficient to reach the Scrambled MG132 level. C) Immunostaining for GluA2/3 on DIV20 
cultured hippocampal neurons transfected at DIV12 with either Scrambled-shRNA or Sh-
TSPAN5 and treated for 90 minutes with either H20 or 100μM leupetin as lysosomes 
inhibitor. Scale bars are 20 μm D) Relative quantification showing that the amount of GluA2/3 
was increased by leupeptin treatment in both Scrambled and Sh-TSPAN5 and that this 
increase reaches similar levels demonstrating that lysosomal degradation is responsible of 
the observed reduction of GluA2.  
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Figure 20. TSPAN5 is localised in recycling endosomes. A) Vesicles fractionation from 
adult rat hippocampi and cortices. The ten fractions obtained were analysed via western 
blotting for different markers: EEA1 for early endosomes, VGlut1 for synaptic vesicles, 
RAB11 and Transferrin Receptor for recycling endosomes. It is possible to observe that 
TSPAN5 co-fractionates with RAB11 and Transferrin Receptor suggesting its presence in 
recycling endosomes. B) TSPAN5 immunostaining in DIV18 cultured hippocampal neurons 
transfected at DIV14 with either RAB4-GFP, RAB7-GFP or RAB11-GFP as markers for early 
endosomes, late endosomes and recycling endosomes respectively. C) Quantification of the 
colocalisation of TSPAN5 with RAB4-GFP, RAB7-GFP and RAB11-GFP measured as 
Mander’s coefficient. It is possible to appreciate that TSPAN5 has a high degree of 
colocalisation with all the three markers but that the coefficient is significantly higher with 
RAB11-GFP suggesting TSPAN5 localisation in recycling endosomes. D) Co-
immunoprecipitation experiment on adult rat hippocampi and cortices lysed in Digitonin 1% 
buffer. The immunoprecipitation of both TSPAN5 and AP-4 ε co-immunoprecipitate 
MyosinVa, an actin motor known to transport AMPA-Rs on recycling endosomes to the 
plasma membrane. 
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Figure 21. TSPAN5 regulates GluA2 recycling without affecting internalization. A) 
Antibody feeding recycling assay for GluA2 on DIV20 cultured hippocampal neurons 
transfected at DIV12 with either the Scrambled-shRNA, Sh-TSPAN5 or Sh-TSPAN5 plus 
TSPAN5-GFP (Rescue). The anti-GluA2 antibody was allowed to bind the receptor and 
internalize for 30 minutes and then allowed to recycle for 0 or 10 minutes. The use of non-
permeabilizing condition allows to visualize the surface and thus recycled receptor (Extra) 
whereas the permeabilizing condition shows the intracellularly retained GluA2 (Intra). B) 
Relative quantification of Extracellular/Total ratio for GluA2 intensity showed that at 0’ the 
three condition are comparable whereas after 10 minutes both the Scrambled and the 
Rescue increased their amount while the Sh-TSPAN5 remains at levels similar to the basal. 
This result demonstrates a dramatic impairment of the recycling of GluA2 upon TSPAN5 
silencing. C) Antibody feeding internalization assay for GluA2 on DIV20 cultured 
hippocampal neurons transfected at DIV12 with either the Scrambled-shRNA or Sh-TSPAN5. 
The anti-GluA2 antibody was allowed to internalize for 0, 5 or 10 minutes and then visualized 
in non permeabilizing condition for the extracellularly retained antibody (Extra) and in 
permeabilizing condition for the internalized one (Intra). D) Relative quantification of the 
Intracellular/Total ration of GluA2 intensity showing that no differences are present for 
internalization when TSPAN5 is silenced. 
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Figure 22. TSPAN5 regulates GluA2 recycling. Schematic model of our hypothesis on 
TSPAN5 role in GluA2 trafficking. The left panel shows that, when TSPAN5 is present, 
GluA2 is trafficked to synapses thanks to TARPs (Stargazin) and AP-4. This complex 
continuously undergoes cycles of internalization and recycling with this latter event being 
promoted by TSPAN5 association through direct binding to AP-4. In the right panel, it is 
shown what we think happen upon TSPAN5 removal. The internalized receptor has no 
signals to be recycled and is thus directed to lysosome for degradation to avoid an excessive 
intracellular accumulation. 
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6. Discussion 
 
In this work we have analysed extensively TSPAN5 expression and function in hippocampal 
neurons. Our hypothesis is that this protein has two distinct functions that have opposed 
importance at different developmental stages. In particular, we have found that TSPAN5 is 
important for the establishment and stabilization of dendritic spines, through the formation of 
Tetraspanin Enriched Microdomain; this process is of particular relevance during the 
maturation of neurons when synaptogenesis occurs (DIV10-12) but remains fundamental 
also in mature neurons to maintain the dynamicity of circuits. However, in mature neurons 
(after DIV18), and thus in formed and stable synapses, TSPAN5 appears to directly regulate 
AMPA-Rs recycling, a process necessary to maintain the correct amount of receptor on the 
surface both in basal and in stimulated conditions. 
 
6.1 TSPAN5 has two distinct functions 
We started our study by analysing the presence of the protein in brain, as two different works 
(Garcia-Frigola et al., 2000) (Garcia-Frigola et al., 2001) have shown the high level of 
expression of TSPAN5 mRNA in different mice brain areas. We were thus not surprised to 
find the expression of the protein in the three areas examined: hippocampus, cortex and 
cerebellum. 
The detection of bands of molecular weight higher than the expected suggested the 
assembly of TSPAN5 in Tetraspanin Enriched Microdomain (Paragraph 2.1.2). 
We then looked for intracellular localisation by means of immunocytochemistry on 
hippocampal neurons following the variation occurring during maturation from DIV1 to DIV18. 
Interestingly, the protein was present in all the phases of maturation starting from the very 
first day of plating. The major differences were observed between the DIV before and after 
14-15. In fact, before this day the protein was broadly distributed with some enrichment in 
growing dendrites and with a pattern resembling plasma membrane proteins with areas of 
brighter signal suggestive of TEMs. Instead, after this DIV the protein was highly enriched in 
perinuclear endoplasmic reticulum and in dendritic spines. We then took advantage of a 
membrane impermeable BS3 crosslinker to verify that the protein was in fact more enriched 
on the surface in immature stages compared to mature neurons.  
We were able to confirm the presence of TSPAN5 in dendritic spines in mature neurons by 
postsynaptic density fractionation and by co-localisation with postsynaptic markers such as 
PSD-95. 
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6.2 TSPAN5 is fundamental for dendritic spines formation 
We designed an shRNA to further investigate the function of the protein. When we knocked 
down TSPAN5 from DIV5 to DIV20 we observed a dramatic reduction in the number of 
dendritic spines recognized both by morphology and by the co-localisation of pre (Bassoon) 
and postsynaptic (GluA2) markers. The reduction was so strong that an indirect effect on 
dendritic spines, as it is observed for many proteins that have functional role in synapses, 
was unlikely, prompting us to investigate a possible direct function of TSPAN5 in dendritic 
spines formation. 
It is known from the literature that tetraspanins have the peculiarity of forming membrane 
domains known as TEMs that have the primary function of facilitating the concentration of 
different proteins (Maecker et al., 1997). As one of the first step of dendritic spine formation 
is the clusterization of Neuroligin 1 on the postsynapse to stabilize the trans-synaptic 
interaction with Neurexins (Barrow et al., 2009), it was logical for us to investigate whether 
TSPAN5 TEMs could be the molecular platforms where this clusterization occurs. 
We first wanted to observe if Neuroligin 1 and GluA2/3 were present in TSPAN5 TEMs.We 
decided to analyse also AMPA-R as representative of proteins that assemble later on the 
forming postsynapse. To address this point we took advantage of the solubility properties of 
TEMs. In fact, these domains, as they are highly enriched in cholesterol compared to the rest 
of the plasma membrane, are partially solubilized with strong detergent such as Triton X-100 
and become almost completely insoluble in buffer containing digitonin that directly binds 
cholesterol as described in paragraph 2.1.2. In this way, we showed that in young neurons 
TSPAN5 was almost completely present in surnatant in RIPA (RadioImmunoPrecipitation 
Assay) buffer lysed neurons whereas it accumulates in the pellet in digitonin lysed neurons. 
Neuroligin 1 and GluA2/3 behaved similarly whereas Tubulin and Transferrin Receptor, used 
as controls, did not. 
This assay unfortunately is based only on lipidic composition of the membranes and thus 
lacks of specificity; the digitonin binding of cholesterol-enriched domain would result in 
precipitation of other domains that present these characteristics such as lipid rafts that have 
been found in synapses (Hering et al., 2003). 
We then decided to observe whether the removal of TSPAN5, and thus of its TEMs, could 
alter the membrane distribution and the clusterization of Neuroligin 1 and GluA2/3. We thus 
infected the neurons with the shRNA for TSPAN5 at DIV5, before synaptogenesis starts, and 
analysed the solubility in digitonin of the two proteins at DIV12 when the peak of 
synaptogenesis is occurring. As expected, the distribution changed in favour of the 
supernatant soluble fraction suggesting that, in absence of TSPAN5, Neuroligin 1 and 
GluA2/3 were shifted to lighter membranes. Concordantly, Transferrin Receptor and Tubulin 
did not change their solubility properties. We also performed BS3 crosslinking experiments 
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and observed that the total and surface level of the two proteins were unaffected excluding 
the possibility of trafficking defects. This result also suggest that the second function of 
TSPAN5 on AMPA-Rs trafficking is not tacking place at this developmental stage and further 
confirm the separation of the two TSPAN5 roles. 
As it is known that both Neuroligin 1 and AMPA-Rs are highly mobile in the membrane 
through lateral diffusion but becomes immobilized at forming synapses due to trapping 
mechanisms (Heine et al., 2008) (Barrow et al., 2009) (Mondin et al., 2011), we wanted to 
investigate if the diffusion of these two proteins was affected by TSPAN5 levels of expression 
and thus by TEMs. 
We used a recently developed technique called uPAINT to follow these movements in super-
resolution. We observed that both Neuroligin 1 and GluA2 increased their mobility upon 
TSPAN5 knockdown suggesting the removal of the trapping trigger. Conversely, TSPAN5 
overexpression was sufficient to reduce the mobility of GluA2; unfortunately, we were not 
able to perform the same experiment for Neuroligin 1. 
Considering that it has been demonstrated that Neuroligin 1 is able to trap AMPA-Rs through 
PSD-95 (Mondin et al., 2011) we cannot exclude that the effect we observed on GluA2 was 
secondary to the one on Neuroligin 1. 
All these results strongly suggest that TSPAN5 is able to organize Tetraspanin Enriched 
Microdomains in young neurons and that these domains accommodate Neuroligin 1, the first 
protein that clusterizes in the site of forming postsynapses, and GluA2, one fundamental 
receptor of excitatory synapses. To date it is still unclear how Neuroligin 1 can accumulate in 
the site of dendritic spine formation. Despite more experiments are needed to further validate 
our hypothesis, it seems very likely that TEMs are able to trap Neuroligin 1 and GluA2 
promoting their accumulation and slowing down their lateral diffusion. This would increase 
the likelihood for Neuroligin 1 to bind trans-synaptically neurexins and, once PSD-95 is 
recruited, for AMPA-Rs to be anchored and stabilized thus enhancing the functionality of the 
synapse. The dramatic loss of dendritic spines in neurons depleted of TSPAN5 suggests that 
this role of TSPAN5 is of high importance for these processes. These results are supported 
by the fact that removal of Neuroligin 1 or AMPA receptors both results in reduction of 
dendritic spine density (Chih et al., 2005) (Passafaro et al., 2003). 
Unfortunately, in our work it is lacking a direct evidence that TSPAN5 TEMs are formed in 
the site where the postsynapse will assemble. This is mainly due to technical problems, as 
no antibodies with high specificity directed against surface epitope of TSPAN5 are available 
and as the probability of observing the formation of a synapse in random dendritic branches 
is prohibitively low. To circumvent these problems we are planning experiments using an 
overexpressed TSPAN5 that will have an AP-tag, as we used for Neuroligin 1 in uPAINT, to 
follow its mobility on the surface of neurons with monomeric streptavidin coupled to 
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fluorophores. We will use this approach in conditions that enhance synapses formation such 
as the use of Neurexin coated beads or plates (Graf et al., 2004) (Czondor et al., 2013) or 
using glutamate uncaging to induce the development of a dendritic spine in a specific 
position (Kwon & Sabatini, 2011). 
We also cannot exclude that other tetraspanins could be involved in similar or in the same 
process as for long time it has been suggested that TEMs accommodate different 
tetraspanins. However, a recent paper that analysed TEMs with super-resolution technique 
(Zuidscherwoude et al., 2015) demonstrated that different tetraspanins form separate 
domains that could then interact without fusion events. This supports the idea that TSPAN5 
alone can organize TEMs fundamental for dendritic spines formation. Another hint that fit our 
hypothesis is that the size of TEMs is, on average, similar to the one of PSD with divergence 
depending on the techniques used to observe the domains but always ranging at least in the 
same order of magnitude (150-500 nm of diameter) (Nydegger et al., 2006) (Zuidscherwoude 
et al., 2015). 
We have shown in the introduction that alterations in the number of dendritic spines, both 
reduced or increased, are usually associated with neuropsychiatric disorders such as 
intellectual disability and autism spectrum disorders (Fiala et al., 2002).  
There are in literature many examples of tetraspanin specific monoclonal antibodies directed 
against extracellular epitopes that could act disrupting or enhancing the formation of TEMs 
depending on the tetraspanin analysed (Hemler, 2008). As these proteins are exposed to the 
extracellular solution, they are relatively easy to reach in “in vivo” condition and they could 
thus be used as target for therapy. The use of a monoclonal antibody, still missing on the 
market, against extracellular epitope of TSPAN5, once assessed if having pro or anti 
aggregation effect on TEMs, could be useful to re-establish the correct number of synapses 
in intellectual disability or autism. 
 
6.3 TSPAN5 regulates AMPA-Rs trafficking 
The initial analysis of TSPAN5 distribution during development showed that the protein 
became enriched in intracellular compartment at mature stages compare to immature. We 
thus decided to investigate this possible second function by looking for intracellular 
interactors using a Yeast Two-Hybrid Screening with the intracellular C terminal tail of the 
protein. This domain shows the highest divergence with the other members of the family. 
We identified AP-4σ, a subunit of the AP-4 complex. The absence on the sequence of 
TSPAN5 of motifs normally recognized by AP-4 (see paragraph 2.3) suggested us that this 
interaction was not only regulating the trafficking of TSPAN5 but could have other more 
important roles. 
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We reconfirmed the interaction in lysates from rat hippocampi in conditions in which TEMs 
were disrupted confirming that this binding was direct. 
As we know from the literature that AP-4 is important for AMPA-Rs trafficking through the 
binding of Stargazin we investigated whether TSPAN5 could be also involved in this process. 
We knocked down TSPAN5 expression in neurons at DIV14, when the peak of 
synaptogenesis is already occurred, to avoid the interference of the previously described 
function of TSPAN5. 
When we analysed Stargazin and GluA2/3 levels in BS3 cross-linked neurons we found that 
Stargazin levels were unaffected as total amount with a little decrease in surface whereas 
GluA2/3 amounts was significantly decreased both in surface and in total level.  
Instead, GluA1 was not reduced but surprisingly increased in the surface amount likely in an 
attempt of the neurons to counterbalance the loss of GluA2. This suggests the specificity of 
TSPAN5 function for GluA2/3 and that Stargazin level was probably less affected as this 
protein is important for all AMPA-Rs subunit traffic. These results are consistent with the 
literature as GluA2/3 receptors are constitutively trafficked whereas GluA1-GluA1 and GluA1-
GluA2 are generally loaded in synapses upon stimulation (Correia et al., 2008). 
We confirmed the reduction of GluA2 surface levels and the increase of GluA1 also via 
immunocytochemistry in transfected neurons. 
As the reduction of GluA2 was pronounced also in the total amount of the protein it meant 
that the defect was probably causing an increased degradation. We treated TSPAN5 
knocked down neurons with either proteasome or lysosomes inhibitor (MG132 and leupeptin 
respectively) and analysed the level of GluA2/3 via immunostaining. MG132 increased the 
amount of the protein but the level was still lower than the one observed in treated 
Scrambled-shRNA. On the other hand, leupeptin rescued almost completely the level of 
GluA2/3 demonstrating that, as expected from a membrane protein, the degradation 
observed was mainly occurring in lysosomes. 
Different results suggested that TSPAN5 could have a role in sorting or trafficking of AMPA-
Rs. First TSPAN5 is associated with AP-4 complex, known to be involved in vesicular 
trafficking; secondly, TSPAN5 was found in membranous intracellular compartments and 
last, GluA2 reduction occurring upon TSPAN5 knockdown was due to lysosomal 
degradation. 
Consequently, TSPAN5 likely resides in some vesicular compartment and we thus wanted to 
investigate its specific localisation. 
We first produced crude synaptosomes from rat hippocampi and then separated vesicles by 
hypo-osmotic shock and sucrose linear gradient. 
We characterized the fraction obtained with different markers and found that TSPAN5 was 
migrating similarly to Transferrin Receptor and RAB11, both markers of recycling 
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endosomes. To confirm the result we transfected GFP-tagged RABs in neurons and 
analysed the co-localisation with TSPAN5. As expected from a transmembrane protein that 
cycles in and out the plasma membrane, TSPAN5 co-localised with RAB-4 (early 
endosomes), RAB-7 (late endosomes) and RAB11 (recycling endosomes) but the degree of 
co-localisation was significantly higher with the latter. 
We also confirmed that TSPAN5 and GluA2/3 were associated in recycling endosomes as 
they co-immunoprecipitated together with MyosinVa, an actin-based motor protein known to 
transport recycling endosomes to the plasma membrane (Correia et al., 2008). 
At this point all the hints suggested that TSPAN5 could regulate the recycling of GluA2 
receptor; to verify this hypothesis we used an antibody feeding assay and found that the 
levels of recycled receptor was similar to the starting point in TSPAN5 knockdown condition 
suggesting a dramatic defect in this process. 
Moreover, the concomitant expression of Sh-TSPAN5 and of TSPAN5-GFP insensitive to the 
shRNA restored the recycling to the levels of Scrambled-shRNA confirming the specificity of 
the impairment observed. 
We also checked, again with an antibody-feeding assay, that the internalization path was not 
affected in TSPAN5 knockdown condition to guarantee the validity of the recycling assay. 
The very strong defect in recycling and the observation of the increased lysosomal 
degradation suggest that TSPAN5 act as a positive regulator of GluA2 recycling. Thus, in 
absence of TSPAN5, all the internalized receptor would get directly degraded dramatically 
decreasing its surface amount. 
As we propose that the role of TSPAN5 in GluA2 recycling is directly occurring through AP-4 
our results seem in apparent discordance with the one published by Matsuda and colleagues 
on the AP-4β knockout mouse (Matsuda et al., 2008) but different hypotheses could be 
proposed to explain the difference. 
Matsuda and colleagues suggest that AP-4 serves as a sorting machinery to direct AMPA-Rs 
and other proteins to the somato-dendritic domain avoiding the mis-localisation to the axons. 
Our results are in apparent contrast, as we did not observe defects in the axon while we 
found a reduction in GluA2 in the surface of dendrites, an effect that was absent in Matsuda’s 
work. However, the authors cannot rule out if AP-4 has any direct effect on the formation or 
regulation of degradation organelles as they admit in the discussion. A function of AP-4 in 
lysosomes has been proposed by different works (Aguilar et al., 2001) (Ruben et al., 2001) 
(Raza et al., 2015): AP-4, similarly to AP-3A (Matsuda et al., 2013), could be involved in 
regulating the sorting of AMPA-Rs to lysosomes and TSPAN5 could instead block this 
sorting and promotes the recycling of the receptors. 
A different hypothesis could be that AP-4 is directly involved in recycling of AMPA-Rs 
together with TSPAN5 and Stargazin. This hypothesis is supported by the fact that many 
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adaptors and regulatory proteins are involved in both sorting to the somato-dendritic 
compartment and in recycling of membrane proteins (Bonifacino & Traub, 2003) (Bonifacino, 
2014). AP-4 could thus act on the two processes and the recycling function could have been 
underestimated in AP-4β KOs due to compensatory effect of other adaptors such as AP-1, 
which present numerous similarities to AP-4. In fact, also AP-1 was shown to bind Stargazin 
and, through it, AMPA-Rs in the same work (Matsuda et al., 2013). Similar compensation is 
less likely to happen in our system that is based on acute removal of the protein instead of 
chronic effects of knockout models. 
We thus thought that TSPAN5 is able to promote GluA2 recycling in mature synapses 
concurring in regulating the precise balance necessary to have functional receptors and that 
this activity occurs thanks to the binding of AP-4 complex and Stargazin. 
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